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Abstract Coupling of endoplasmic reticulum (ER) stress to dimerisation-dependent activation of
the UPR transducer IRE1 is incompletely understood. Whilst the luminal co-chaperone ERdj4
promotes a complex between the Hsp70 BiP and IRE1’s stress-sensing luminal domain (IRE1LD) that
favours the latter’s monomeric inactive state and loss of ERdj4 de-represses IRE1, evidence linking
these cellular and in vitro observations is presently lacking. We report that enforced loading of
endogenous BiP onto endogenous IRE1a repressed UPR signalling in CHO cells and deletions in
the IRE1a locus that de-repressed the UPR in cells, encode flexible regions of IRE1LD that mediated
BiP-induced monomerisation in vitro. Changes in the hydrogen exchange mass spectrometry profile
of IRE1LD induced by ERdj4 and BiP confirmed monomerisation and were consistent with active
destabilisation of the IRE1LD dimer. Together, these observations support a competition model
whereby waning ER stress passively partitions ERdj4 and BiP to IRE1LD to initiate active repression
of UPR signalling.
Introduction
In eukaryotes, the endoplasmic reticulum (ER) is the central organelle for the synthesis of proteins
destined for secretion and membrane insertion. The ER lumen harbours a specialised protein folding
and processing machinery that constitutes the protein folding capacity of the ER. To ensure that the
environment for productive protein maturation is maintained, both folding capacity and the inward
flux of newly synthesised proteins are regulated by a pervasive negative feedback signalling path-
way, the unfolded protein response (UPR) (Kozutsumi et al., 1988; Cox et al., 1997). In mammalian
cells, this pathway involves three known signaling branches each directed by a unique signal trans-
ducer resident in the ER membrane, IRE1, PERK and ATF6. An imbalance between folding load and
capacity (ER stress) activates these sensors initiating a rectifying transcriptional and translational
response to defend protein-folding homeostasis in the compartment (reviewed in Walter and Ron,
2011). While details of downstream events and their physiological significance are relatively well
characterised (reviewed in Wang and Kaufman, 2016), the molecular mechanisms of the earliest
events in UPR activation remain incompletely understood.
IRE1, conserved in all eukaryotes and therefore the best-studied UPR transducer (Cox et al.,
1993; Mori et al., 1993), detects ER stress via its luminal domain (IRE1LD), initiating dimerisation-
dependent autophosphorylation of its cytosolic domain (Shamu and Walter, 1996). The subsequent
allosteric activation of the cytosolic endoribonuclease domain (Lee et al., 2008) leads to unconven-
tional splicing of the mRNA encoding the XBP1/HAC1 transcription factor (Cox and Walter, 1996;
Yoshida et al., 2001; Calfon et al., 2002), thereby promoting translation of an effector that drives a
conserved gene-expression program.
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Two models have been put forth to describe how IRE1LD senses ER stress. A direct binding model
posits that unfolded proteins act as ligands stabilising IRE1’s dimeric/oligomeric state thereby pro-
moting its activation. This model is supported by the crystal structure of the core luminal domain
from S. cerevisae IRE1, showing an IRE1LD dimer interface traversed by a groove with architectural
similarity to the major histocompatibility peptide-binding complexes (MHCs) (Credle et al., 2005).
Peptide ligands of the yeast IRE1LD have been identified and their addition to dilute solutions of
yeast IRE1LD enhances the population of higher order species, although a clear shift from monomers
to dimers was not readily observable (Gardner and Walter, 2011).
The luminal domain of the broadly expressed alpha isoform of human IRE1 (hIRE1aLD) also crys-
tallises as a dimer, with an overall architecture similar to the yeast protein, however, barring confor-
mational changes, the MHC-like groove is too narrow to accommodate a peptide (Zhou et al.,
2006). Recently, peptides have been identified that bind hIRE1LD and affect its oligomeric state, as
assessed by analytical ultracentrifugation (AUC). Moreover, nuclear magnetic resonance (NMR)
reported on peptide-induced structural rearrangements within the hIRE1aLD that also affected resi-
dues near the MHC-like groove. Hence, it has been proposed that the structure of Zhou et al.
(2006) represents a ‘closed’ conformation of the peptide-binding groove that can shift towards an
‘open’ state to allow peptide binding (Karago¨z et al., 2017). However, a co-crystal structure of the
ligand-bound yeast or human IRE1LD is not available and it remains unclear if and how peptide
ligands affect hIRE1LD dimerisation, the first crucial step of its activation.
An alternative hypothesis posits that IRE1 is repressed by interacting with a major component of
the ER folding machinery, the heat-shock protein (Hsp70) chaperone BiP. It is proposed that upon
stress, unfolded proteins accumulate and compete for BiP interaction, thereby kinetically disrupting
the inhibitory IRE1-BiP complex. This chaperone inhibition model draws parallels between the regu-
lation of the UPR and its cytosolic counterpart, the heat-shock response, in which chaperones associ-
ate with the transcription factor Hsf1, in eukaryotes, and s32, in bacteria, to interfere with their
activity (Abravaya et al., 1992; Shi et al., 1998; Tomoyasu et al., 1998). This model is supported
by an inverse correlation between ER stress-induced IRE1 activity and the amount of ER-localised
BiP recovered in complex with it (Bertolotti et al., 2000; Okamura et al., 2000; Oikawa et al.,
2009).
eLife digest Cells produce many protein molecules. These are made of chains of building
blocks called amino acids that then fold into three-dimensional shapes. Specialist proteins known as
chaperones assist this folding process. For example, the chaperone BiP helps other proteins fold in a
compartment within the cell called the endoplasmic reticulum.
To match the supply of chaperones to the demand of unfolded proteins, cells have stress
receptors, such as IRE1 in the endoplasmic reticulum. IRE1 responds to changing levels of unfolded
proteins by generating signals that tell cells whether they need more chaperones. Previous studies in
a test tube suggest that when levels of unfolded proteins are low, BiP represses IRE1 signalling.
However, when the levels of unfolded proteins increase, the unfolded proteins compete with IRE1
for BiP, releasing the brake BiP imposes on IRE1 signalling. It remained unclear if BiP regulates IRE1
in the same way in living cells.
To address this question, Amin-Wetzel, Neidhardt et al. studied IRE1 signalling in mammalian
cells grown in the laboratory. The experiments revealed that cells containing a modified version of
IRE1 to which BiP binds more strongly had less IRE1 signalling. On the other hand, cells containing
versions of IRE1 that BiP binds less well had more active IRE1 signalling. These findings suggest that
in cells, as in the test tube, unfolded proteins and IRE1 compete for BiP binding. This relationship
comprises a simple mechanism allowing cells to sense and respond to the burden of unfolded
proteins in their endoplasmic reticulum.
Over time, the amount of unfolded proteins in the cell likely contributes to the development of
aging-related diseases such as adult-onset diabetes. A better understanding of how cells handle
unfolded proteins may lead to more effective treatments for these diseases.
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Further molecular insight into the chaperone inhibition mechanism was gained recently by the dis-
covery of ERdj4 as an ER-localised J-domain protein that selectively represses IRE1 activity in vivo
and loads BiP onto the IRE1LD, thereby promoting monomerisation in vitro (Amin-Wetzel et al.,
2017). Whilst other modes of BiP binding to the IRE1LD have been proposed (Carrara et al., 2015;
Kopp et al., 2018) the aforementioned observations suggest a mechanism in which BiP engages the
IRE1LD as an Hsp70 substrate: ATP-bound BiP initially interacts with the IRE1LD with high kon and
high koff rates and only captures IRE1
LD as a substrate (in the ADP bound state, with low koff rates)
after ERdj4 co-chaperone-instructed ATP hydrolysis. This model draws on the conventional view
whereby J-domain proteins act as adaptors that enable efficient substrate recognition via their diver-
gent targeting domains and subsequent binding of Hsp70s, promoted by their conserved J-domain
that stimulates Hsp70’s ATPase activity (reviewed in Kampinga and Craig, 2010). J-domain co-chap-
erones act in concert with nucleotide exchange factors (NEFs, reviewed in Behnke et al., 2015) to
accelerate Hsp70s’ cycles of substrate binding and release, resulting in substrate-selective ultra-affin-
ity (Misselwitz et al., 1998; De Los Rios and Barducci, 2014), which is the basis for the assembly of
Hsp70-substrate complexes.
Whilst ERdj4’s repressive action on IRE1 signalling in cells and its ability to promote a complex
between IRE1LD and BiP that favours the former’s monomeric state in vitro fit the chaperone inhibi-
tion model, they remain correlative findings and may be causally unrelated. For example, it is possi-
ble that ERdj4’s repressive action in cells arises from its role in eliminating IRE1LD activating ligands
and not from catalysing the repressed, monomeric IRE1LD-BiP complex observed in vitro. Here, in
support of the chaperone inhibition model, we report that enforced targeting of endogenous BiP to
endogenously-expressed IRE1LD represses UPR signalling in cells, thereby establishing that BiP can
directly repress IRE1 in vivo and that features of the IRE1LD that specify its repression in cells also
specify its ability to undergo actively-driven monomerisation by ERdj4 and BiP in vitro.
Results
BiP binding to IRE1LD represses IRE1 activity in cells
An inverse correlation between ER stress-induced IRE1 activity and the amount of BiP recovered in
complex with it has been previously observed (Bertolotti et al., 2000; Okamura et al., 2000;
Oikawa et al., 2009) but a causal link between BiP binding and IRE1 activity status had never been
conclusively established. To assess the effect of BiP binding on the activity of IRE1 in vivo, we modi-
fied the endogenous Ern1 locus to encode an ER targeted J-IRE1 fusion protein consisting of IRE1a’s
endogenous signal peptide, an N-terminally fused J-domain (derived from ERdj4) followed by the
endogenous IRE1a coding sequence (Figure 1—figure supplement 1). The alpha isoform accounts
for all measurable activity in CHO cells and is referred to as IRE1 hereafter. By employing this fusion
protein, we expected to stimulate BiP’s ATPase activity in close proximity to the IRE1LD thereby pro-
moting formation of an IRE1-BiP complex. As control, a point mutant ERdj4 J-domain was used that
had the histidine of the highly conserved HPD motif replaced by glutamine (JQPD) compromising the
stimulation of BiP‘s ATPase activity (Wall et al., 1994). The glycine-phenylalanine-rich (G/F) region of
ERdj4 was included as a flexible linker, to allow the J-domain to explore the entire surface of IRE1LD.
We deemed that low level expression of endogenous IRE1 (and hence J-IRE1) would minimise IRE1-
independent effects of this chimeric J-domain protein on the ER folding environment, effects that
could not be excluded as having contributed to the previously-noted repressive effect of ERdj4
over-expression on the UPR (Amin-Wetzel et al., 2017).
Using an Ern1 null cell line with a genomic deletion encompassing the IRE1LD-encoding exons 2–
12 (DIRE1, previously described in Kono et al., 2017), we reconstituted the endogenous locus with
either wild-type IRE1, J-IRE1 or JQPD-IRE1 fusion. Additionally, the cell lines stably expressed XBP1s::
Turquoise and CHOP::GFP reporters that are controlled by the IRE1 and PERK UPR branches,
respectively. Flow cytometry analysis showed that reconstitution of the locus with wild-type IRE1 res-
cues the non-responsive XBP1s::Turquoise phenotype of the DIRE1 cells towards stress induced by
tunicamycin (Figure 1A). In comparison, cells expressing the J-IRE1 fusion showed low XBP1::Tur-
quoise reporter levels, indicating repressed IRE1 activity, even under stress. Repression was depen-
dent on the integrity of the J-domain as DIRE1 cells reconstituted with the mutant JQPD-IRE1
acquired nearly wild-type stress responsiveness. The J-IRE1 protein was not otherwise compromised,
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Figure 1. Fusion of ERdj4’s J-domain to IRE1LD promotes efficient BiP association thereby repressing IRE1 activity in cells. (A) Two dimensional plots of
CHOP::GFP and XBP1s::Turquoise signals from CHO-K1 dual UPR reporter cells stably expressing the indicated IRE1 variants [IRE1 wild-type (wt), J-IRE1
or JQPD-IRE1 fusion; see Figure 1—figure supplement 1A, for schema of the alleles] from the endogenous Ern1 locus untreated and treated with the
ER stressor tunicamycin (Tm). Clones used for the analysis were derived from an IRE1 null (DIRE1) parental cell line. A representative data set out of
Figure 1 continued on next page
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as it was still able to respond to the ER stressor SubA, a protease that inactivates BiP by cleaving its
interdomain linker (Paton et al., 2006) (Figure 1B). These findings are consistent with BiP serving as
a direct trans-acting factor to specify repression mediated by a J-domain presented in cis to the
IRE1LD.
A role for the cis-active J-domain in recruiting BiP to the IRE1LD is supported by immunoprecipita-
tion (IP) of endogenous IRE1 prepared from the cells described above. More BiP was recovered in
complex with the J-IRE1 chimera compared to the wild-type IRE1 whilst the mutant JQPD-IRE1 fusion
associated with a similar amount of BiP as the wild-type (Figure 1C), which is in accordance to their
similar phenotype detected by flow cytometry.
To further validate these in vivo observations, we reconstituted the system in vitro using recombi-
nant proteins purified from bacteria. First, pull down of either C-terminally biotinylated IRE1LD
(IRE1LD-bio) or J-IRE1LD (J-IRE1LD-bio) was performed. We assessed the formation of a BiP-IRE1LD-
bio complex on SDS-PAGE after recovery on immobilised streptavidin (Figure 1D). Whilst BiP recov-
ery in complex with IRE1LD-bio was dependent on the presence of both ERdj4 and ATP in the bind-
ing assay, complex formation of BiP and J-IRE1LD-bio required only ATP.
Next, we tested how BiP binding affected J-IRE1LD’s oligomeric status in vitro using a Fo¨rster res-
onance energy transfer (FRET)-based assay to continuously monitor the monomer-dimer equilibrium
(as described previously, Amin-Wetzel et al., 2017). A donor IRE1LD labelled with Oregon Green
(OG) was pre-equilibrated either with an IRE1LD or J-IRE1LD acceptor molecule labelled with TAMRA
(TMR). As previously observed, BiP, ERdj4, and ATP were all required to monomerise the IRE1LD
homodimer as reflected in the time-dependent increase in donor fluorescence until a kinetically
maintained pseudo steady state was reached (Figure 1E). In contrast, heterodimeric FRET pairs con-
taining the J-IRE1LD fusion and IRE1LD were monomerised by BiP in an ATP-dependent manner, but
did not require ERdj4 in trans. The nucleotide-dependent, BiP-induced monomerisation of the
J-IRE1LD containing heterodimer occurred with an approximately four-fold higher initial velocity and
a higher plateau in the pseudo steady state of the reaction. Taken together these findings suggest
that the fused J-domain enables efficient formation of the IRE1LD-BiP complex, thereby promoting
monomerisation, which leads to repression of IRE1 activity.
In vitro characterisation of direct binding of unfolded proteins to
IRE1LD as modelled by the MPZ-N peptide
To examine the role of peptides in regulating the monomer-dimer equilibrium of IRE1LD and hence
its activity, we turned to a 12-mer peptide (MPZ-N) derived from myelin protein zero. MPZ-N is the
best studied ligand for mammalian IRE1LD and was recently proposed to directly interact with the
peptide-binding groove thereby influencing IRE1LD‘s oligomeric status (Karago¨z et al., 2017). When
introduced into the FRET-based assay, MPZ-N had no measurable effect on donor fluorescence.
Figure 1 continued
three independent experiments is shown. Note the low XBP1::Turquoise intensity in stressed J-IRE1 rescued DIRE1 cells. (B) Two dimensional plots of
mCherry and XBP1s::Turquoise signals of clones described in ‘A’ transiently transfected with a plasmid encoding the SubA protease, which cleaves BiP
at its interdomain linker and an mCherry fluorescent transfection marker. The inactive SubAS272A mutant was used as control. Representative data from
nine biological repeats is shown. (C) Immunoblot (IB) of endogenous IRE1 and associated BiP recovered from the indicated cell lines by
immunoprecipitation (IP) of IRE1. Quantification of the ratio of BiP to IRE1 signals in three independent experiments is shown on the right
(mean ± standard deviation, n.s.: not significant, *: p<0.05, unpaired parametric Student’s t test). BiP in input cell lysates is provided as loading control.
(Figure 1—source data 1) (D) Coomassie-stained SDS-PAGE gel of biotinylated IRE1LD (IRE1LD-bio) and a fusion of ERdj4’s J-domain to IRE1LD (J-
IRE1LD-bio, as in ‘A’) and BiP, both recovered on a streptavidin matrix from samples constituted as indicated. Protein concentrations were 5 mM IRE1LD-
bio variants, 30 mM BiP, 8 mM ERdj4, and 2 mM ATP. Proteins were eluted in SDS sample buffer. A representative data set out of three independent
experiments is shown. (E) Time-dependent change in donor fluorescence of the indicated IRE1LD FRET pair incubated at t = 0 with the components
shown to the right. IRE1LD proteins were either labelled with the donor molecule Oregon green 488 (OG) or the acceptor molecule TAMRA (TMR).
Protein concentrations were 0.2 mM IRE1LD FRET pair, 30 mM BiP, 2.5 mM ERdj4 and 2 mM ATP. A representative graph of three independent
experiments is shown (Figure 1—source data 2).
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Source data for Figure 1C.
Source data 2. Source data for Figure 1E .
Figure supplement 1. Modification of the endogenous Ern1 locus to introduce IRE1LD variants.
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However, as the optical readout of this assay is sensitive mostly to monomerisation (as reflected in
an increase in donor fluorescence, Figure 1E) it would be a relatively insensitive measure of MPZ-N
peptide driven dimerisation. Therefore, we sought different assays to report on the ability of the
MPZ-N peptide to promote IRE1LD dimers.
The distribution of IRE1LD between monomers and dimers can be tracked by size exclusion chro-
matography (SEC), as evidenced by the concentration-dependence of the peak elution time of
IRE1LD and two dimerisation-compromised mutants: a previously characterised W125A variant
(Zhou et al., 2006) and a new, more severe P108A variant (Figure 2—figure supplement 1A). Both
mutations are predicted to decrease hydrophobic interactions across the dimer interface (Figure 2—
figure supplement 1B). Addition of MPZ-N peptide (at concentrations exceeding the reported K1/
2 max for binding of 16 mM, Karago¨z et al., 2017) did not affect the peak elution time of IRE1
LD,
itself introduced into the assay at 500 nM, near the Kd for IRE1
LD dimerisation (Zhou et al., 2006)
(Figure 2A and B).
To confirm these observations, we made use of an alternative assay reporting on IRE1LD’s dimer-
isation status. To this end, we employed a modified IRE1LD Q105C that forms a disulphide across the
dimer interface, creating a covalently stabilised dimer when placed in oxidising conditions (Fig-
ure 2—figure supplement 1C) and the aforementioned dimerisation-compromised versions of the
IRE1LD (W125A and P108A). Differential scanning fluorimetry (DSF) revealed that the melting tem-
perature (Tm) of disulphide-linked IRE1
LD Q105C SS was ~10 ˚C higher than the Tm the wild-type pro-
tein, a Tm difference that was effaced by reduction of the dimer-stabilising disulphide (Figure 2—
figure supplement 1D). By contrast, the IRE1LD monomeric variants exhibited a Tm 5–10 ˚C lower
than the wild-type. These observations established a correlation between the monomer-dimer equi-
librium and the Tm of the protein consistent with dimerisation-mediated stabilisation of the IRE1
LD.
A ligand, stabilising the IRE1LD dimer, is predicted to increase the Tm, however, addition of MPZ-N
peptide had no effect on the Tm of IRE1
LD (Figure 2—figure supplement 1D, the significance of the
lowering of Tm observed at the highest concentrations of peptide remains to be determined).
To gain insight into the mode of MPZ-N binding to IRE1LD we made further use of the disulphide-
linked IRE1LD Q105C SS. The crystallised IRE1LD Q105C SS dimer proved identical in structure to the
wild-type protein (root-mean squared deviation (RMSD) of 0.46 A˚ over 227 Ca atoms) except for the
presence of a conspicuous density corresponding to a C105-C105 trans-protomer disulphide,
thereby locking the proposed binding groove in the ‘closed’ conformation (Figure 2C, Figure 2—
figure supplement 1E and Table 1). Nonetheless, a fluorescence polarisation binding assay, using
FAM-labelled MPZ-N, showed that binding to the IRE1LD was not compromised by the disulphide
(Figure 2D), leading us to conclude that MPZ-N does not obligatorily bind within the proposed
MHC-like groove of the IRE1LD. This conclusion is also consistent with the paramagnetic relaxation
enhancement (PRE) experiments with IRE1LD and an MPZ-proxyl-labelled peptide (Karago¨z et al.,
2017), which present a distance constraint of 10 A˚ between Ile186 of the IRE1LD and the labelled
Cys5 of the peptide. Figure 2—figure supplement 2 shows that the extended peptide is free to
explore the entire surface of one face of the IRE1LD and may therefore bind in locations other than
the MHC-like groove, without violating this distance constraint.
Identification of regions in IRE1LD involved in BiP-mediated regulation
of its activity
Given the evidence for BiP’s role in IRE1 repression, we tried to identify regions in IRE1LD that might
be important for such regulation. BiP, as an Hsp70 chaperone, typically interacts with unfolded or
flexible regions in its client proteins (Ru¨diger et al., 1997) and we held that this might also be the
case for its interaction with the IRE1LD. Therefore, we sought clues to map these flexible regions by
collecting data on the structural dynamics of IRE1LD in solution as evaluated by hydrogen-1H/2H-
exchange experiments in combination with mass spectrometry (HX-MS).
IRE1LD was pre-equilibrated for 30 min at 30˚C followed by an exchange reaction in deuterium
oxide (D2O) buffer for 30 and 300 s. Subsequent analysis of deuteron incorporation was performed
as described previously (Hentze and Mayer, 2013). Information on peptic peptides covering 85% of
the IRE1LD sequence was obtained (Table 2). The extracted percentage of exchange (%ex) for each
peptic peptide contained information about the thermodynamic stability of structural elements, the
hydrogen bonding and solvent accessibility of backbone amide hydrogens (Figure 3A left panel).
Projection of these values onto the crystal structure showed that regions in the hydrophobic core
Amin-Wetzel et al. eLife 2019;8:e50793. DOI: https://doi.org/10.7554/eLife.50793 6 of 35
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Figure 2. Binding of MPZ-N peptide to IRE1LD does not promote IRE1LD dimerisation. (A) Size-exclusion chromatography (SEC) elution profiles of
TAMRA (TMR)-labelled wild-type IRE1LD at the indicated concentrations in presence and absence of MPZ-N peptide. TMR fluorescence is plotted
against elution time (see: Figure 2—source data 1). (B) SEC elution profiles (as in ‘A’), but with protein absorbance at 280 nm (A280) plotted against
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Figure 2 continued on next page
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exhibited significant protection from exchange (low %ex), whereas surface exposed areas were more
dynamic (high %ex) (Figure 3A right panel). This method identified the region encompassing resi-
dues 303–378 as being especially flexible, a conclusion consistent with the observation that though
it was present in the constructs used for crystallisation, residues 308–357 were resolved in neither
the crystal structures of wild-type IRE1LD (Zhou et al., 2006) (Figure 3A right panel dotted line) nor
Figure 2 continued
of free peptide (eluting at ~24 min). The heterogenous peaks eluting between 15 and 20 min in the sample loaded with 1 mM MPZ-N peptide, likely
reflected peptide oligomerisation (see: Figure 2—source data 1). (C) Cartoon representation of the IRE1LD dimer (PDB: 2HZ6) is shown on the left with
coloured secondary structures (cyan for helices, red for sheets and magenta for loops). The Gln105 side chain is shown as sticks, a closer view of which
is shown on the top right. The bottom right panel shows a similar view of the Gln105Cys mutant (crystallised here), which forms a disulphide bond,
covered with clear electron density (black mesh represents the 2mFo   DFc map, contoured at 1.0 s, including density within 2 A˚ of the cysteine
residues). (D) Anisotropy of FAM labelled MPZ-N peptide (100 nM) in presence of increasing concentrations of either wild-type IRE1LD or disulphide-
linked dimeric IRE1Q105C SS. Shown are data from three independent experiments (mean ± SD). Curve fitting was performed in Prism GraphPad 7.0
using Equation 2 in Materials and methods (see: Figure 2—source data 2).
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Source data for Figure 2A and B.
Source data 2. Source data for Figure 2D.
Figure supplement 1. Biochemical properties of disulphide-linked dimeric IRE1LD Q105C SS and monomeric variants used to study MPZ-N’s interaction
with IRE1LD.
Figure supplement 1—source data 1. Source data for Figure 2—figure supplement 1A.
Figure supplement 1—source data 2. Source data for Figure 2—figure supplement 1D.
Figure supplement 2. Implications of the distance constraint arising from the paramagnetic relaxation enhancement (PRE) experiments with IRE1LD and
an MPZ-proxyl-labelled peptide (Karago¨z et al., 2017) to the possible modes of peptide binding.
Table 1. Data collection and refinement statistics of IRE1LDQ105C SS.
Data collection
Synchrotron stations Dls i04-1
Space group P6522
a,b,c; A˚ 182.77, 182.77, 68.45
a, b, g ; 0 90.00, 90.00, 120.00
Resolution, A˚ 91.39–3.55 (3.89–3.55)*
Rmerge 0.180 (2.242)
*
I/s(I) 11.7 (1.5)*
CC1/2 1.000 (0.797)*
No. of unique reflections 8590 (1996)*
Completeness, % 100.0 (100.0)*
Redundancy 19.3 (19.9)*
Refinement
Rwork/Rfree 0.323/0.332
No. of atoms (non H) 1784
Average B-factors 127
RMS Bond lengths A˚ 0.003
RMS Bond angles,0 0.606
Ramachandran favoured region, % 95.85
Ramachandran outliers, % 0
MolProbity score† 1.51 (100th)
PDB code 6SHC
* Values in parentheses are for highest-resolution shell.
† 100† 100th percentile is the best among structures of comparable resolutions. 0th percentile is the worst.
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the disulphide-linked IRE1LD Q105C SS variant here. Similar characteristics apply to residues 379–444,
covering the so-called tail region that connects the structured core of the IRE1LD with the transmem-
brane domain (Figure 3A right panel dotted line and Figure 3—figure supplement 1A). Moreover,
the latter residues overlap with a region of IRE1LD implicated in its basal repression in an overexpres-
sion cell-based assay (Oikawa et al., 2007; Oikawa et al., 2009).
To probe the putative loop (residues 308–357) and the tail region (residues 390–444) for their
importance in maintaining the repressed state of IRE1 in vivo, we devised a CRISPR-Cas9 mutagene-
sis strategy (Figure 3B). By targeting only unstructured regions within IRE1LD, we hoped to preserve
the integrity of the core structure whilst favouring mutations that might de-repress IRE1 activity.
After introducing a set of guide RNAs targeting the region of interest together with the Cas9 endo-
nuclease into cells, error prone non-homologous end joining (NHEJ) resulted in a series of mutations,
Table 2. List of IRE1LD peptic peptides analysed by hydrogen-1H/2H-exchange mass spectrometry
(HX-MS) containing the respective m/z values, charge (z) and sequence of each peptide.
Note that the N-terminal amide hydrogen of each peptic fragment exchanges too fast to be detect-
able with this method. Hence, the N-terminal residue was excluded from the data analysis.
Residues M/z Z Sequence
24–36 631.345 2 STSTVTLPETLL
37–45 938.478 1 FVSTLDGSL
46–59 396.730 4 HAVSKRTGSIKWTL
77–85 927.435 1 LPDPNDGSL
86–106 779.087 3 YTLGSKNNEGLTKLPFTIPEL
96–106 636.380 2 LTKLPFTIPEL
107–119 1316.680 1 VQASPSRSSDGIL
120–128 390.199 3 YMGKKQDIW
130–134 735.424 1 YVIDLL
134–145 631.832 2 LTGEKQQTLSSA
147–157 1090.563 1 ADSLSPSTSLL
157–168 730.874 2 LYLGRTEYTITM
168–175 522.242 2 MYDTKTRE
176–183 535.772 2 LRWNATYF
186–195 1031.447 1 AASLPEDDVD
196–208 727.837 2 YKMSHFVSNGDGL
209–221 703.343 2 VVTVDSESGDVLW
221–232 697.856 2 WIQNYASPVVAF
233–240 1050.537 1 YVWQREGL
241–248 332.864 3 RKVMHINV
253–258 406.735 2 LRYLTF
280–287 444.28 2 KSKLTPTL
288–296 1017.525 1 YVGKYSTSL
297–302 655.273 1 YASPSM
303–316 474.268 3 VHEGVAVVPRGSTL
317–335 956.978 2 PLLEGPQTDGVTIGDKGES
343–360 534.307 4 VKFDPGLKSKNKLNYLRN
365–378 503.588 3 IGHHETPLSASTKM
379–404 516.606 6 LERFPNNLPKHRENVIPADSEKKSFE
410–424 810.376 2 VDQTSENAPTTVSRD
410–443 727.149 5 VDQTSENAPTTVSRDVEEKPAHAPARPEAPVDSM
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Figure 3. Identification of flexible regions in IRE1LD that are important for the regulation of IRE1 activity in cells. (A) Left panel shows a bar diagram of
the percentage of amide hydrogen exchange (%ex) of the indicated by IRE1LD segments after 30 and 300 s incubation in D2O. The amino acids (aa)
covered by the peptic fragments are indicated on the left. Exchange was corrected for back exchange using a fully deuterated IRE1LD preparation.
Protein concentration was 5 mM. Shown are the data of three independent experiments (mean ± standard deviation). Right panel shows a cartoon of
Figure 3 continued on next page
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ranging from small in-frame indels at a single guide site to larger ones spanning two guide sites. The
IRE1 reporter was used to select rare clones exhibiting a de-repressed IRE1 phenotype (XBP1s::Tur-
quoise bright). The CHOP::GFP reporter was used to exclude clones exhibiting a general perturba-
tion of ER protein homeostasis. Iterative rounds of fluorescence-activated cell sorting (FACS)
enriched the XBP1s::Turquoise bright population. Clones that had acquired IRE1-independent
XBP1s::Turquoise reporter expression were purged based on their unresponsiveness to the IRE1
inhibitor 4m8c (Cross et al., 2012). The Ern1 locus of individual clones with deregulated IRE1 activity
found in the final pool was sequenced (Figure 3C left panel). As expected, all the putative deregu-
lating deletions/mutations maintained the frame of the IRE1 coding sequence (Figure 3C right panel
and Figure 3—figure supplement 1B). These observations suggested that deletions of unstructured
regions of IRE1LD could deregulate IRE1 activity.
Characterisation of IRE1LD deletion constructs in vivo and in vitro
To confirm the suggested role of deletions of the loop and the tail region of IRE1LD in deregulating
its activity in cells, we reconstituted the endogenous Ern1 locus of the DIRE1 cell line with the most
extensive IRE1 deletion variants identified above: the Dloop (missing residues 313–338), the Dtail
(missing residues 391–444) or both (DD). The reconstituted alleles de-repressed IRE1 activity, as indi-
cated by the elevated basal XBP1s::Turquoise signal (Figure 4A and Figure 4—figure supplement
1A). The IRE1 DD double deletion had the strongest deregulated phenotype under basal conditions.
Like the shorter deletions, the IRE1 DD double deletion nonetheless retained some responsiveness
to stress, albeit with a narrowed dynamic range (Figure 4A, compare untreated to tunicamycin-
treated samples).
To establish if the deregulating deletion affected the association of the IRE1LD with BiP, we com-
pared the amount of BiP that co-immunoprecipitated with the endogenously expressed wild-type or
IRE1 DD (Figure 4B). Despite variation in the total BiP signal intensity in the three independent
repeats (Figure 4B, lower panel), paired analysis revealed that significantly less BiP was associated
with the IRE1 DD mutant. The same was observed in a transient transfection system in which IRE1’s
cytosolic effector domains were replaced with glutathione S-transferase (GST). Compared to the
wild-type IRE1LD-GST bait, the amount of BiP recovered by glutathione affinity chromatography in
association with the variants was significantly lower in context of the single deletions and even lower
in case of the double-deletion IRE1LD DD-GST (Figure 4C).
Together, the observations described above confirm a role for the flexible regions of the IRE1LD
in maintaining IRE1 in a repressed state in vivo and suggest that such repression may reflect a role
for these flexible regions in specifying BiP binding. To follow up on this suggestion, Bio-Layer Inter-
ferometry (BLI) was used to compare BiP’s association with the biotinylated wild-type or double-
deleted IRE1LD DD immobilised on the sensor. Immersing the sensor into a solution containing ERdj4,
BiP and ATP gave rise to an association curve, that was reproducibly attenuated when IRE1LD DD was
bound as a ligand compared to the wild-type IRE1LD (Figure 5—figure supplement 1A, left traces).
Figure 3 continued
the IRE1LD dimer (PDB: 2HZ6) with the left protomer coloured according to %ex at 30 s (areas with no sequence coverage are uncoloured). The location
of the putative loop (residues 308–357) and the tail (residues 390–444) are schematically represented as dotted lines (see: Figure 3—source data 1) (B)
Schematic description of a directed in vivo CRISPR-Cas9 mutagenesis strategy to probe regions of IRE1LD for their relevance to regulating activity in
CHO-K1 cells. Cas9 guides (red triangles) targeted sites across the Ern1 genomic locus encoding the protein’s region of interest. Transfection of
individual or pairs of guides resulted in a collection of mutations (insertions and deletions, depicted as blue and red lines). Cell harbouring rare de-
repressing mutations of IRE1 (blue) were selected by fluorescence-activated cell sorting (FACS) gated on XBP1s::Turquoise high and CHOP::GFP low
signals. The resultant clones were isolated and genotyped. (C) Left panel is a histogram of XBP1s::Turquoise intensity of CHO-K1 dual UPR reporter cell
populations transfected with guide-Cas9 encoding plasmids targeting a putative unstructured loop (aa 308–357) within IRE1LD (identified in ‘A’). XBP1s::
Turquoise bright cells within population 0 were collected by FACS (FACS1) yielding population 1, followed by a second round of enrichment for bright
cells (FACS2 yielding population 2). Population 2 was treated with the IRE1 inhibitor 4m8c to select against clones exhibiting IRE1-independent reporter
activity. The final population was genotypically analysed (representative sequences are shown on the right). Frameshift mutations are coloured in blue
and Cas9 cut sites are indicated below.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. Source data for Figure 3A.
Figure supplement 1. IRE1’s tail region is involved in maintaining the repressed state of IRE1 in vivo.
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Figure 4. Cells expressing IRE1LD deletion variants exhibit a de-repressed IRE1 phenotype that correlates with less BiP bound to IRE1. (A) Bar diagram
of median XBP1::Turquoise and CHOP::GFP signals from untreated and tunicamycin (Tm)-treated CHO-K1 dual UPR reporter cells with Ern1 alleles
encoding wild-type (wt) or the indicated deletion variants of IRE1 (Dloop, missing residues 313–338, Dtail, missing residues 391–444, or DD, missing
both). Data from four independent experiments is shown [mean ± standard deviation (SD), **: p<0.01, ****: p<0.0001, one-way ANOVA with Sidak’s
multiple comparison test] (Figure 4—source data 1). (B) Representative immunoblot (IB) of endogenously-expressed wt or the IRE1 DD deletion mutant
(see ‘A’) and associated BiP recovered by immunoprecipitation (IP) of IRE1. BiP in input cell lysates is provided as a loading control. Quantification of
the ratio of BiP to IRE1 signals after IP of three independent experiments is shown below (mean ± SD, *: p<0.05, ratio paired parametric Student’s t
test) (see: Figure 4—source data 2) (C) Left panel shows a representative immunoblot of the indicated IRE1 variants with glutathione S-transferase
(GST) replacing the cytosolic domain. The proteins were introduced into CHO-K1 cells by transient transfection, and the associated endogenous BiP
recovered by glutathione pull down. BiP in input cell lysates is provided as a loading control. Quantification of the ratio of BiP to IRE1 signals in the IP
of three independent experiments is shown to the right (mean ± SD, *: p<0.05, **: p<0.01, ***: p<0.001, one-way ANOVA with Sidak’s multiple
comparison test).
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Source data for Figure 4A.
Source data 2. Source data for Figure 4B.
Figure 4 continued on next page
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A similar qualitative defect in BiP binding to IRE1LD DD was also observed when the full-length ERdj4
was replaced by its isolated J-domain (that lacks the regions required for specific targeting to the
IRE1LD) (Figure 5—figure supplement 1A, right traces).
This last observation suggested that the defect in J-domain-mediated BiP binding to IRE1LD DD,
had a component that was independent of recruitment of ERdj4 to IRE1LD by the former’s targeting
domain and implied that the deleted region of IRE1LD had a role in specifying BiP association. This
was explored further using J-IRE1LD fusion proteins as BLI ligands to enforce ATP hydrolysis by BiP
in proximity to the wild-type or double-deleted IRE1LD (independent of the role these flexible
regions of IRE1LD might have in J-domain co-chaperone recruitment). Immersing a BLI sensor loaded
either with J-IRE1LD or J-IRE1LD DD into a solution containing BiP and ATP revealed a reproducible
defect of BiP association to J-IRE1LD DD (Figure 5A left panel). No association was observed in pres-
ence of the substrate binding-deficient BiPV461F mutant. The dissociation in presence of ATP
remained similar for both wild-type and J-IRE1LD DD (Figure 5A right panel), as expected of a pro-
cess limited by BiP’s rate of nucleotide exchange.
The measurements above report on BiP’s interaction with the IRE1LD in the context of J-domain-
mediated, ATP hydrolysis-driven ultra-affinity (Misselwitz et al., 1998; De Los Rios and Barducci,
2014). To examine the role of IRE1LD’s flexible regions in its affinity for BiP-ADP (an interaction that
reports on a segment of the ultra-affinity cycle) we combined BiP with C-terminally biotinylated
IRE1LD (either IRE1LD-bio or IRE1LD DD-bio) in presence of ADP and absence of J-domain protein.
Given the slow association of BiP-ADP with substrates and the slow dissociation of BiP oligomers a
lengthy equilibration (16 hr) was allowed. Almost three-fold less BiP was recovered in complex with
IRE1LD DD-bio than with IRE1LD-bio (Figure 5B). BiP association was concentration-dependent, desta-
bilised by ATP and was not observed with BiPV461F. Coupling of BiP’s two domains was dispensable
for this interaction with IRE1LD-bio, as it was also observed with the domain-uncoupled BiPADDA
(Preissler et al., 2015a). Together, these observations point to a role for the flexible regions of
IRE1LD in specifying BiP association as a conventional substrate of this Hsp70. An additional role for
the flexible regions in ERdj4 recruitment was not evident within the sensitivity of the tools available
to us, and therefore remains unexcluded.
BiP binding in vitro promotes dissociation of the IRE1LD dimer (Amin-Wetzel et al., 2017 and
Figure 1E). Therefore, we employed the same FRET-based assay to determine if impaired BiP bind-
ing affected monomerisation of IRE1LD DD -containing dimers. Wild-type fluorescent donor-labelled
IRE1LD was allowed to dimerise with acceptor-labelled IRE1LD or IRE1LD DD and the rate at which BiP,
ERdj4 and ATP promoted dissociation of these dimers was measured by following the increase in
donor fluorescence over time. The initial velocity of BiP-mediated monomerisation of the IRE1LD DD
containing heterodimers was considerably slower than monomerisation of wild-type homodimers
(Figure 5C).
In BLI experiments, BiP association to monomeric IRE1LD P108A was faster than to the enforced
dimeric IRE1LD Q105C SS (Figure 5—figure supplement 1B), raising the concern that both diminished
BiP binding to the IRE1LD DD observed in BLI (Figure 5A) and the slower monomerisation of the
IRE1LD DD containing FRET pair (Figure 5C) might reflect intrinsically enhanced stability of the IRE1LD
DD-containing dimers. However, SEC of the purified proteins performed over a range of protein con-
centrations reported on similar affinities of the wild-type and IRE1LD DD dimers (Figure 5—figure
supplement 1C and D) yielding K1/2 max values in the same order of magnitude as the KD of dimer-
isation measured by AUC (Zhou et al., 2006). Together, these observations suggest that diminished
BiP binding to IRE1LD DD resulted in an impairment of BiP-driven IRE1LD monomerisation.
BiP-driven monomerisation of IRE1LD assessed by HX-MS
To complement the kinetic observations pointing to impaired BiP-driven monomerisation of
IRE1LD DD with structural correlations, HX-MS was performed. To establish the HX-MS signature of
monomerisation, deuteron incorporation was compared between wild-type and dimerisation-defec-
tive IRE1LD W125A or IRE1LD P108A mutants. This reported on monomerisation-induced deprotection
Figure 4 continued
Figure supplement 1. Single or double deletion of a flexible loop and the tail within IRE1LD de-repressed IRE1 basal activity.
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Figure 5. Impaired BiP binding and monomerisation of IRE1LD DD in vitro. (A) Left panel shows Bio-Layer Interferometry (BLI)-derived association (assoc.)
and dissociation (dissoc.) traces of streptavidin sensors loaded with the indicated biotinylated ligands [a fusion of ERdj4’s J-domain to IRE1LD wild-type
(wt) or DD, as in Figure 1D] and exposed sequentially to the indicated solutions of analyte (containing wt BiP or the client-binding mutant BiPV461F). A
representative experiment of three independent repetitions is shown. The traces were subtracted against a background derived from a BLI sensor with
Figure 5 continued on next page
Amin-Wetzel et al. eLife 2019;8:e50793. DOI: https://doi.org/10.7554/eLife.50793 14 of 35
Research article Cell Biology
of several peptic peptides from the IRE1LD (Figure 6A). Projecting these areas onto the crystal struc-
ture revealed that monomerisation affected HX at the dimer interface but also in parts further away
(Figure 6B). IRE1LD monomerisation thus induced structural rearrangements across the protein.
Moreover, the difference plot in HX reported on a gradation between both mutant variants, as
IRE1LD P108A had an enhanced signature of monomerisation compared to IRE1LD W125A, matching
the hierarchy of dimer instability observed by SEC and DSF analysis (Figure 2—figure supplement
1A and D, respectively).
A similar deprotection signature, affecting most of the peptic peptides that are exposed upon
monomerisation, was observed when IRE1LD was incubated with BiP and ERdj4 in presence of ATP
(Figure 6C upper row, box 1: residues 77–128 and box 2: residues 280–302). Monomerisation was
dependent on the integrity of all components of the reaction, as neither the substrate binding
BiPV461F mutant nor the ERdj4QPD supported the pattern of deprotection observed in the monomeric
versions of IRE1LD (the significance of the protection afforded by BiPV461F and ERdj4QPD to some
peptides is presently unknown). IRE1LD DD exhibited delayed monomerisation in presence of BiP,
ERdj4 and ATP: IRE1LD DD’s signature of monomerisation was absent after 30 s incubation in D2O
(Figure 6C lower row) and was faint even after an exchange reaction of 300 s (Figure 6—figure sup-
plement 1B and C lower row). In the absence of BiP, ERdj4 and ATP the difference plot comparing
deuteron incorporation into IRE1LD and IRE1LD DD was negligible (Figure 6—figure supplement 1D)
providing independent confirmation of the SEC measurements pointing to similar stability of the
wild-type and IRE1LD DD mutant dimer (Figure 5—figure supplement 1C and D). Thus, HX-MS pro-
vided an orthogonal assay to the FRET-based measurement, reporting on BiP-mediated monomer-
isation of IRE1LD and a kinetic defect in this process brought about by deletion of flexible regions in
the luminal domain that enforce IRE1’s repressed state in cells.
Close inspection of the HX-MS data revealed that some of the peptides (e.g. peptides 636.3802+
and 655.273+ corresponding to residues 96–106 and 297–302, respectively) exhibited clear bimodal
isotope distribution. This characteristic is a signature for the EX1 exchange regime, indicative of the
presence of two discrete subpopulations of molecules: a more folded and therefore low exchanging
subpopulation and a more open, high exchanging subpopulation (Figure 7—figure supplement 1A
and Materials and methods section). The contribution of low and high exchanging subpopulations to
each isotope peak was determined by fitting the isotope peak maxima versus m/z data points
(Figure 7A) to a two Gaussian distribution model (Hentze et al., 2016). From the fit parameters the
fraction of each isotope peak that belongs to the low and high exchanging subpopulation was calcu-
lated [Figure 7—figure supplement 1A (blue and red parts of the bars) and 1B]. Comparison with
the unexchanged and the 100% control samples revealed that the low exchanging subpopulation
was largely protected from HX, whereas the high exchanging subpopulation had almost all amide
Figure 5 continued
no ligand and the BLI signals (displacement) were set to zero after the first washing step. Quantification of the dissociation rate constants koff after
association in presence of 0.15 mM BiP and 2 mM ATP are shown to the right. Traces were fitted to a two-phase dissociation function in Prism
GraphPad 7.0. Shown are the mean ± standard deviation (SD) of three independent repetitions (n.s.: not significant, unpaired parametric Student’s t
test). (B) Coomassie-stained SDS-PAGE gel of biotinylated wt IRE1LD (IRE1LD-bio), double deleted IRE1LD DD (IRE1LD DD-bio) and BiP, recovered on a
streptavidin matrix from samples constituted as indicated. 2 mM ATP was used during wash steps of the matrix when indicated. A representative data
set is shown. Quantification of the ratio of BiP to IRE1 signals in the relevant samples after pull down from three independent experiments is shown on
the right (mean ± SD, *: p<0.05, **: p<0.01, one-way ANOVA with Sidak’s multiple comparison test). (C) Time-dependent change in donor fluorescence
of the indicated IRE1LD FRET pair incubated at t = 0 with the components shown to the right. The asterisks mark samples set up with a mock FRET
sensor lacking the IRE1LD donor-labelled molecule. Protein concentrations were 0.2 mM FRET pair, 30 mM BiP, 2.5 mM full-length ERdj4 (or its isolated
J-domain) and 2 mM ATP. A representative experiment of three independent repetitions is shown. When indicated, the data points were fitted to a
one-phase association function in Prism GraphPad 7.0; the initial velocity represents the slope of the curve at time point zero (mean ± SD, ***: p<0.001,
unpaired parametric Student’s t test) (see: Figure 5—source data 1).
The online version of this article includes the following source data and figure supplement(s) for figure 5:
Source data 1. Source data for Figure 5A.
Source data 2. Source data for Figure 5C.
Figure supplement 1. The DD deletion does not affect the stability of the IRE1LD dimer.
Figure supplement 1—source data 1. Source data for Figure 5—figure supplement 1B.
Figure supplement 1—source data 2. Source data for Figure 5—figure supplement 1C.
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Figure 6. BiP-mediated monomerisation of IRE1LD DD assessed by hydrogen exchange mass spectrometry (HX-MS). (A) Difference plot of deuteron
incorporation comparing wild-type (wt) IRE1LD with the monomeric mutants IRE1LD W125A (orange trace) or IRE1LD P108A (pink trace) after 30 s incubation
in D2O [see Table 2 for the amino acid (aa) sequence of the individual segments]. Protein concentration was 5 mM. Shown are data from three
independent experiments [mean ± standard deviation (SD)]. Boxes 1 and 2 highlight regions of greater hydrogen exchange (HX) in the monomeric
mutants compared to wt IRE1LD that were analysed in presence of chaperones in ‘C’ (see Figure 6—source data 1). (B) Cartoon representation of the
IRE1LD dimer (PDB: 2HZ6) coloured according to the difference of deuteron incorporation between wt and IRE1LD P108A after 30 s of incubation in D2O
(from ‘A’). (C) Difference plot of the deuteron incorporation between the untreated sample and samples exposed to the indicated additives. The data
for the same peptic peptides from wt IRE1LD and the IRE1LD DD mutant are displayed separately. Protein concentrations were 5 mM IRE1LD (wt or DD
mutant), 30 mM BiP (wt or V461F mutant), 6 mM ERdj4 (wt or QPD mutant) and 2 mM ATP. Shown are the means ± SD of three data sets acquired after
30 s incubation in D2O (the corresponding 300 s data set is presented in Figure 6—figure supplement 1A and C) (see Figure 6—source data 2).
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Source data 1. Source data for Figure 6A and Figure 6—figure supplement 1A.
Figure 6 continued on next page
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protons exchanged for deuterons. Moreover, the low exchanging subpopulation converted into the
high exchanging subpopulation with time (Figure 7—figure supplement 1A, compare 30 and 300 s
incubation in D2O).
Interestingly, the degree of conversion into the high exchanging subpopulation was more pro-
nounced for the IRE1LD P108A monomeric mutant than for wild-type IRE1LD and essentially complete
after 300 s (Figure 7—figure supplement 1A left panel). SEC analysis of IRE1LD P108A showed that
at 5 mM (the concentration at which the protein was diluted into D2O) it is mostly monomeric (Fig-
ure 2—figure supplement 1A). Hence, these data suggest that the conversion from the low
exchanging subpopulation to the high exchanging subpopulation was a feature of the monomeric
state.
HX is a quasi-irreversible reaction: Once a molecule has transiently assumed a high exchanging
conformation (and undergone the exchange) the signature of having transited through a high
exchanging conformation remains even if the protein is in a conformational equilibrium (and individ-
ual molecules transit back to the low exchanging conformation). Thus, HX-MS detects the transition
to the high exchange endpoint. The observation that for wild-type IRE1LD the transition from the low
(blue) to the high (red) exchanging population occurred with much slower kinetics than for IRE1LD
P108A (Figure 7—figure supplement 1A, compare left panel, monomeric IRE1LD P108A with the right
panel, wild-type IRE1LD) suggests that a higher proportion of IRE1LD monomers increased the transi-
tion rate, whereas the presence of IRE1LD dimers leads to a reduction of the rate constant. Hence,
the extracted transition rate ktrans reports on IRE1
LD’s monomer-dimer equilibrium during the
reaction.
Next, we compared the ktrans of peptic peptide 655.273
+ from wild-type IRE1LD in presence and
absence of BiP, ERdj4 and ATP. Due to pre-incubation of the reactions, the three-protein system
already had a higher proportion of monomeric IRE1LD at the point of dilution into D2O (reflected in
a greater proportion of the high mass population at the earliest measurement). Nevertheless, an
accelerated time-dependent increase in the proportion of monomeric IRE1LD was observed in the
BiP-treated sample, indicating an increase in ktrans (Figure 7A and B). Acceleration of ktrans was also
observed with peptide 636.3802+ in presence of BiP, ERdj4 and ATP (Figure 7C and Figure 7—fig-
ure supplement 1C).
Because it is affected by peptide-specific flexibility, ktrans itself is not a direct measure of the first
order dissociation rate of the IRE1LD dimer (its koff), however, the difference observed in ktrans for
any individual peptide measured under two conditions mainly reports on differences in IRE1LD dimer
dissociation. Therefore, these findings imply that BiP-induced IRE1LD monomerisation has a compo-
nent arising from active destabilisation of the dimer.
Discussion
The notion that a chaperone machinery with an Hsp70, such as BiP, as its terminal effector might
negatively regulate activity of an upstream UPR transducer, such as IRE1, has the appeal of simplic-
ity: Hsp70’s can potently affect the structure and function of their clients. The level of free BiP is
kept low by inactivating oligomerisation and AMPylation and is further limited by client titration
(Preissler and Ron, 2019). Therefore, the availability of a BiP-dependent machinery to serve as an
active repressor of IRE1 is a plausible inverse measure of the level of ER stress. For years, the inverse
relationship between the recovery of BiP in complex with IRE1 and exposure of cells to conditions
causing ER stress has provided the only experimental support for this chaperone repression model
(Bertolotti et al., 2000; Okamura et al., 2000; Oikawa et al., 2009). The recent establishment of
an ATP- and co-chaperone-dependent system in which BiP promotes a pool of monomeric, inactive-
state IRE1LD further supports the model by revealing BiP’s potential to affect a major change in
IRE1’s activity in vitro (Amin-Wetzel et al., 2017). Here, we provide much needed further support
Figure 6 continued
Source data 2. Source data for Figure 6C and Figure 6—figure supplement 1C.
Figure supplement 1. HX-MS evidence for impaired BiP- and ERdj4-driven monomerisation of IRE1LD DD.
Figure supplement 1—source data 1. Source data for Figure 6—figure supplement 1E.
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for the chaperone repression model by demonstrating that directing endogenous BiP to bind
endogenous IRE1LD as a substrate also attenuates signalling in cells, thus revealing BiP’s potential as
a direct IRE1 repressor in vivo.
A structure-based targeted approach identified regions of IRE1LD that impart a repressed state in
vivo. The same regions proved important for ATP and co-chaperone-dependent BiP-mediated
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Figure 7. Analysis of bimodally-distributed isotope clusters of IRE1LD peptic peptides reveals active destabilisation of the IRE1LD dimer by BiP. (A)
Intensity distributions of the isotope clusters of peptide 655.273+ (residues 297–302) from IRE1LD, untreated or exposed to BiP, ERDj4 and ATP (30 min
at 30˚C) following different incubation times in D2O, as indicated. Curves are fits of the sum of two Gaussian distributions (Prism GraphPad 7.0, see
Equation 4 in Materials and methods). A representative plot of three independent experiments is shown. (see: Figure 7—source data 1) (B) Plot of
time-dependent change in the fractional contribution of high mass species to the isotope clusters of peptide 655.273+ (from ‘A’) calculated as
described in Figure 7—figure supplement 1A and B. Shown are data points from three independent samples of IRE1LD in presence and absence of
BiP, ERdj4 and ATP. The curves were fitted to a one-phase association model in Prism GraphPad 7.0. Data for a second informative peptide is shown in
Figure 7—figure supplement 1C. (C) Bar diagram of the transition rate constant ktrans extracted by analysis of bimodal distributions in the isotope
clusters of peptic fragments 636.3802+ and 655.273+ from IRE1LD in presence and absence of BiP, ERdj4 and ATP (from Figure 7B and Figure 7—
figure supplement 1C). All the data points from three independent experiments are shown and the mean ± standard deviation (**: p<0.01, ****:
p<0.0001, one-way ANOVA with Sidak’s multiple comparison test).
The online version of this article includes the following source data and figure supplement(s) for figure 7:
Source data 1. Source data for Figure 7A and B and Figure 7—figure supplement 1A, B, C.
Figure supplement 1. Analysis of the bimodal distributions of the isotope clusters detected by HX-MS.
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conversion of active-state IRE1LD dimers to inactive-state monomers in vitro and their presence
accelerated the formation of an ATP and co-chaperone-dependent complex with BiP in vitro. Mono-
merisation was observed in both a FRET-based assay, involving labelled molecules of IRE1LD, and in
an HX-MS assay with intact molecules, thus establishing a firm correlation between the determinants
of IRE1 that regulate its function in vivo and those that specify its regulation in vitro by a BiP-led
machinery (Figure 8).
Correlation between factors involved in BiP regulation of IRE1 in vitro and UPR activity in vivo
have been previously noted: Deregulated AMPylation of BiP activates IRE1 in cells (Preissler et al.,
2015b) and BiP AMPylation in vitro blocks IRE1LD monomerisation (Amin-Wetzel et al., 2017).
ERdj4 acts in concert with BiP to monomerise IRE1LDin vitro and loss of ERdj4 from cells de-
represses IRE1 in vivo (Amin-Wetzel et al., 2017). However, genetic lesions in trans-acting ER-local-
ised factors also have the potential to broadly alter the state of the ER and thereby unleash pro-
cesses that affect IRE1 independently (of any direct interaction with BiP). Indirect effects are less
likely a consequence when IRE1LD is modified in cis. Therefore, whilst it is impossible to rule out con-
tributions from factors other than the BiP machinery to the deregulation of IRE1 that arises from
deletion of the unstructured regions of its luminal domain, attenuation of BiP-mediated IRE1 repres-
sion in cells emerges as a parsimonious unifying explanation for the findings presented here.
It is further notable that there is nothing in our observations to speak against the possibility that
extended regions of unfolded ER proteins serve as activating ligands of IRE1 by binding across the
IRE1LD dimer interface and stabilising it (Karago¨z et al., 2019). IRE1 signalling is triggered by an
imbalance between unfolded proteins and BiP. The latter results in more potential ligands for IRE1
and fewer molecules of its client-free ATP bound BiP repressor (Bakunts et al., 2017; Vitale et al.,
2019). Thus, the two proposed mechanisms for IRE1 activation, could well co-exist. However, our
findings do raise questions regarding the strength of the experimental evidence supporting the cur-
rent ideas how unfolded proteins may serve as activating ligands of IRE1. The evidence rests promi-
nently on the activity of a peptide, MPZ-N, nominated as a model activating ligand of IRE1LD
(Karago¨z et al., 2017). Our findings do not support the notion that this peptide specifically engages
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Figure 8. Cartoon depicting features of BiP-mediated regulation of IRE1 activity. In stressed cells unfolded proteins compete for BiP, exposing IRE1LD
to a default dimeric active state, specified by the kinetics of the monomer-dimer equilibrium (left panel). In compensated cells BiP (assisted by ERdj4
and possibly other J-domain proteins, not shown) binds flexible regions of IRE1LD. Engagement of these regions in the IRE1LD dimer may favor active
dimer disassembly by entropic pulling or allosterically induced conformational changes (right panel). BiP binding to the same flexible regions of the
IRE1LD monomer, may inactivate IRE1 by disfavoring re-dimerisation (right panel). The dynamic nature of BiP binding, which entails cycles for ATP
hydrolysis-driven client engagement and nucleotide exchange-mediated release, ensures that IRE1 activity is kinetically coupled to the balance
between unfolded protein load and folding capacity of the cell.
Amin-Wetzel et al. eLife 2019;8:e50793. DOI: https://doi.org/10.7554/eLife.50793 19 of 35
Research article Cell Biology
the MHC-like groove traversing the dimer interface, as a disulphide, crystallographically proven to
lie across this groove, thereby locking the helices in a ‘closed’ conformation, had no effect on the
binding of MPZ-N to IRE1LD. Furthermore, MPZ-N binding to IRE1LD did not stabilise it thermody-
namically, whereas the aforementioned disulphide, which mimics the proposed dimer-stabilising
effect of a bound peptide, increased the melting temperature IRE1LD by 10 ˚C. Nor did MPZ-N pro-
mote a shift in the monomer-dimer equilibrium of IRE1LD as assessed by SEC. These concerns, along
with the lack of crystallographic data supporting engagement of the groove by ligands, suggest the
need for further experiments to test the role of unfolded proteins as direct IRE1 activators.
HX-MS analysis revealed neither an ERdj4-dependent nor BiP and ATP-dependent protection
within IRE1LD to suggest their binding site. It has been proposed that ERdj4’s bacterial homolog,
DnaJ, exploits mostly side chain interactions to bind clients, with a strong preference for aromatic
residues (Ru¨diger et al., 2001). Such interactions, were they to serve as the basis for IRE1LD recogni-
tion by ERdj4, would be only visible to HX-MS if they stabilised the underlying secondary structure.
Given the conventional mode of BiP action on IRE1LD (ATP and co-chaperone-dependent and abol-
ished by the BiPV461F mutation), one would expect protection of 4–5 hydrogen amides by IRE1LD
engagement in the chaperone’s substrate-binding domain. However, partial occupancy of multiple
sites may have diluted any HX-MS signature of BiP binding. This is supported by the observation
that at the concentrations of ERdj4 and BiP used in the HX-MS assay, the FRET assay reported peak
fluorescence of only ~40% of the unquenched donor (at the kinetically driven pseudo steady state
plateau of the reaction, Figure 1E). Thus, the lack of a clear ATP- and ERdj4-dependent BiP binding
signature is consistent with the dynamic nature of BiP’s interaction with IRE1LD. Interestingly, we
observed an ATP-independent protection against deuteron incorporation within IRE1LD that was
also evident in presence of the substrate binding-defective BiPV461F. This might reflect a non-conven-
tional interaction of BiP’s nucleotide binding domain with IRE1LD, as proposed by the Ali lab
(Kopp et al., 2018; Kopp et al., 2019). However, this protection is not correlated to the activity-
state of IRE1LD and its significance thus remains to be established.
Mechanistically, BiP’s interaction with IRE1LD shares features with other situations in which
Hsp70s bind to native clients thereby regulating their activity: DnaJ-directed, DnaK-mediated desta-
bilisation of E. coli s32 (Rodriguez et al., 2008), functional regulation of the glucocorticoid receptor
(Kirschke et al., 2014), regulation of the activity of the tumour suppressor p53 (Boysen et al.,
2019; Dahiya et al., 2019), Hsf1 regulated heat shock gene expression (Abravaya et al., 1992) and
Hsc70-mediated destabilisation of clathrin coats (Sousa et al., 2016). All these have in common cli-
ent destabilisation and likely initiate at unstructured regions of the substrate. Thus, it seems reason-
able to suggest that an important aspect of BiP’s ability to affect the disposition of IRE1LD’s
monomer-dimer equilibrium arises from its interaction with the flexible regions identified here.
Bimodal analysis of the HX-MS data suggested that ERdj4-directed BiP binding can accelerate
dimer disassembly. This is consistent with the ability of the IRE1LD dimer to serve as a ligand for
ERdj4 and BiP (here and Amin-Wetzel et al., 2017). While BiP binding to and stabilisation of IRE1LD
monomers may also contribute to shifting the monomer-dimer equilibrium towards the former, the
HX-MS experiment suggests an (additional) active role for BiP in dimer destabilisation. This may arise
from a BiP-binding induced bias of the ensemble of IRE1LD dimers towards conformers preferentially
populated in the monomer. A similar mechanism of conformational selection has been proposed for
DnaK-mediated destabilisation of E. coli s32 (Rodriguez et al., 2008). Such ‘allosteric’ action is con-
sistent with the observation that monomerisation has effects on IRE1LD structure that are far
removed from the dimer interface. Alternatively, BiP binding may destabilise the IRE1LD dimer by
entropic pulling (De Los Rios et al., 2006), as has been suggested in Hsc70-mediated destabilisation
of clathrin coats (Sousa et al., 2016) (Figure 8). The latter mechanism would be further favoured by
assembly of BiP oligomers on the surface of the IRE1LD, a possibility consistent with the >1:1 stoichi-
ometry of BiP:IRE1LD complexes observed in some experiments (Amin-Wetzel et al., 2017)
(although the latter may also reflect multiple BiP binding sites).
As shown here, flexible regions of IRE1LD contribute measurably to its repression in cells and to
BiP-driven monomerisation in vitro. This observation is consistent with the idea that these regions
serve as initiation points for BiP binding to promote dimer disassembly via entropic pulling, allosteri-
cally induced conformational changes or both. Considerable redundancy seems built into the pro-
cess, as the deregulated IRE1DD allele retained a measure of stress responsiveness in cells and the
IRE1LD DD dimer was still slowly undone in a BiP-dependent process in vitro. Such redundancy has
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been observed previously: in both yeast and human, IRE1 deletion of the tail region connecting the
structured core of IRE1LD to the transmembrane domain partially deregulated IRE1, whilst retaining
partial responsiveness to ER stress (Oikawa et al., 2007; Oikawa et al., 2009). Redundancy in the
structural features of the IRE1LD dimer that render it a substrate for BiP-dependent disassembly and
the non-equilibrium kinetic nature for BiP’s action could serve as the basis for a smoothly graded
response to variation in the levels of ER stress.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation
Source or
reference Identifiers
Additional
information
Strain, strain
background
(Escherichia coli)
BL21 C3013 E. coli NEB Cat no: C3013I
Strain, strain
background
(Escherichia coli)
Origami B(DE3) E. coli Novagen/MERCK Cat no: 70837
Antibody Anti-mouse IRE1a serum
(rabbit polyclonal)
Bertolotti et al., 2000 NY200 used at 1/1000
Antibody anti-hamster BiP
(chicken polyclonal)
Avezov et al., 2013 Anti-BiP used at 1/1000
Antibody Anti-GST
(polyclonal rabbit)
Ron and Habener, 1992 Anti-CHOP used at 1/1000
Cell line,
(Cricetulus griseus)
Clone S21 a derivative of
RRID: CVCL_0214
Sekine et al., 2016 CHO-K1 S21 CHO CHOP::GFP,
XBP1s::Turquoise dual UPR
reporter cell line
Cell line,
(Cricetulus griseus)
CHO-K1 S21 CHOP::GFP,
XBP1s::Turquoise DLD 15
Kono et al., 2017 DIRE1 CHO CHOP::GFP,
XBP1s::Turquoise dual UPR
reporter, Ern1 null cell line
Cell line,
(Cricetulus griseus)
CHO-K1 S21 CHOP::GFP,
XBP1s::Turquoise
IRE1 wild-type
This paper IRE1 wild-type CHO CHOP::GFP,
XBP1s::Turquoise dual UPR
reporter, Ern1 null cell line
reconstituted with
IRE1 wild-type
Cell line,
(Cricetulus griseus)
CHO-K1 S21 CHOP::GFP,
XBP1s::Turquoise IRE1 DD
This paper IRE1 DD CHO CHOP::GFP,
XBP1s::Turquoise dual UPR
reporter, Ern1 null cell line
reconstituted with IRE1 DD
(missing residues 313–338
and 391–444)
Peptide,
recombinant protein
MPZ-N Karago¨z et al., 2017 MPZ-N 12-mer peptide (MPZ-N)
derived from myelin
protein zero
Peptide,
recombinant protein
FAM-MPZ-N Karago¨z et al., 2017 FAM-MPZ-N FAM labelled 12-mer peptide
(MPZ-N) derived from
myelin protein zero
Software, algorithm Prism GraphPad
Software, algorithm FlowJo,LLC,
Software, algorithm Data Analysis 4.1 Bruker
Chemical
compound, drug
Tunicamycin Melford Cat no: T2250
Chemical
compound, drug
2-Deoxyglucose Sigma Cat no: D6134
Chemical
compound, drug
4m8c Tocris Bioscience Cat no: 4479
Chemical
compound, drug
Digitonin Calbiochem Cat no: 300410
Continued on next page
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Continued
Reagent type
(species) or resource Designation
Source or
reference Identifiers
Additional
information
Chemical
compound, drug
Biotin-NHS ester Sigma Cat no: H1759
Chemical
compound, drug
Protease inhibitors Sigma Aldrich (MERCK) S8830
Chemical
compound, drug
Oregon Green-
iodoacetic acid
ThermoFisher Cat no: O6010
Chemical
compound, drug
TAMRA-maleimide Sigma Cat no: 94506
Chemical
compound, drug
Phosphocreatine Sigma Cat no: 10621714001
Chemical
compound, drug
Creatine kinase Sigma Cat no: C3755
Recombinant
DNA reagent
haBiP_27–654_
pQE10 (plasmid)
Petrova et al., 2008 UK173 N-terminally His6-tagged
hamster BiP
Recombinant
DNA reagent
haBiP_27–654_V461F_
pQE10 (plasmid)
Petrova et al., 2008 UK182 N-terminally His6-tagged
hamster BiP V461F
Recombinant
DNA reagent
haBiP_27–654_ADDA_
pQE10 (plasmid)
Preissler et al., 2015a UK984 N-terminally His6-tagged
hamster BiP ADDA
Recombinant
DNA reagent
H6_Ulp1_pET28b (plasmid) This study UK1249 H6-tagged Ulp1
Recombinant
DNA reagent
pCEFL_mCherry_
3XFLAG_C (plasmid)
Sekine et al., 2016 UK1314 pCEFL with 3XFLAG_C
tagged from mCherry-
tagged plasmid
Recombinant
DNA reagent
BPPTSP_SubA_22–347_3XFLAG
_KDEL_pUC57_Acc65I_based_
pCEFL_mCherry (plasmid)
This study UK1452 3xFLAG-tagged SubA with
KDEL on mCherry-tagged
plasmid
Recombinant
DNA reagent
BPPTSP_SubA_22–347_S272A_
3XFLAG_KDEL_pUC57_Acc65I_
based_pCEFL_mCherry (plasmid)
This study UK1459 3xFLAG-tagged SubAS272A
with KDEL mCherry-
tagged plasmid
Recombinant
DNA reagent
hIRE1_19–486_dC_GST_
del3UTR _pCDNA3 (plasmid)
Amin-Wetzel et al., 2017 UK1703 C-GST-tagged
cysteine-free human IRE1
Recombinant
DNA reagent
CHO_IRE1_guideC15.1_
pSpCas9(BB) 2A-mCherry
(plasmid)
Kono et al., 2017 UK1903 Cas9 and guide targeting
IRE1 in CHO-K1 DLD clone
15 (mCherry-tagged)
Recombinant
DNA reagent
CHO_IRE1_hIRE1-LD_
reptemp4_pCR-Blunt2-
TOPO (plasmid)
Kono et al., 2017 UK1968 Repair template for
wild-type IRE1 reconstitution
in CHO-K1 cells
Recombinant
DNA reagent
Smt3_cgERdj4_24–222_
pET-21a (plasmid)
Amin-Wetzel et al., 2017 UK2012 N-Smt3-tagged Chinese
amster ERdj4 24–222
Recombinant
DNA reagent
Smt3_J4_domain_24–90_
pET-21a (plasmid)
Amin-Wetzel et al., 2017 UK2041 N-Smt3-tagged Chinese
hamster ERdj4 24–90
Recombinant
DNA reagent
pET22b_H7_Smt3_Ire1a_
LDDC_24_444 (plasmid)
This study UK2042 N-His6-Smt3-tagged
wild-type human
IRE1LD24–444
Recombinant
DNA reagent
pET22b_H7_Smt3_Ire1a_
LDDC_24_444 Q105C (plasmid)
Amin-Wetzel et al., 2017 UK2045 N-His6-Smt3-tagged
cysteine-free human
IRE1LD Q105C24–444
Recombinant
DNA reagent
pET22b_H7_Smt3_Ire1a_
LDDC_24_444 R234C (plasmid)
Amin-Wetzel et al., 2017 UK2048 N-His6-Smt3-tagged
cysteine-free
human IRE1LD24–444,
R234C (FRET probe)
Recombinant
DNA reagent
pET22b_H7_Smt3_Ire1a_
LDDC_24_444 S112C (plasmid)
Amin-Wetzel et al., 2017 UK2076 N-His6-Smt3-tagged
cysteine-free human
IRE1LD24–444,
S112C (FRET probe)
Continued on next page
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Continued
Reagent type
(species) or resource Designation
Source or
reference Identifiers
Additional
information
Recombinant
DNA reagent
Smt3_cgERdj4_24–222_
GS6_MalE_pET21a
(plasmid)
Amin-Wetzel et al., 2017 UK2108 N-Smt3-ERdj4-MBP
Chinese hamster 24–222
Recombinant
DNA reagent
Smt3_cgERdj4_24–222_
QPD_GS6_MalE_pET21a
(plasmid)
Amin-Wetzel et al., 2017 UK2119 N-Smt3-ERdj4-MBP
Chinese hamster
residues 24–222 H54Q
Recombinant
DNA reagent
IRE1a_LD_DC_24–443_
AviTag_H6_pET30a
(plasmid)
This study UK2246 C-Avi-His6-tagged
cysteine-free human
IRE1LD24–444
Recombinant
DNA reagent
pET22b_H7_Smt3_
Ire1a_LDDC_Q105C_
24_390 (plasmid)
This study UK2304 N-His6-Smt3-tagged
cysteine-free human
IRE1LD Q105C24–390
Recombinant
DNA reagent
pET22b_H7_Smt3_Ire1a
_LD_dC_24_390_D313–338_
S112C (plasmid)
This study UK2370 N-His6-Smt3-tagged
cysteine-free human
IRE1LD DD (313-338, 391-444)
S112C, FRET probe
Recombinant
DNA reagent
CHO_IRE1_hIRE1-LD_d313
-338_reptemp4_pCR-
Blunt2-TOPO (plasmid)
This study UK2384 Repair template for IRE1
Dloop (d313-338) reconstitution
in CHO-K1 cells
Recombinant
DNA reagent
CHO_IRE1_hIRE1-LD_d391-
444_reptemp4_pCR-Blunt2-
TOPO (plasmid)
This study UK2385 Repair template for IRE1
Dtail (d391-444) reconstitution
in CHO-K1 cells
Recombinant
DNA reagent
CHO_IRE1_hIRE1-LD_d313-
338_d391-440_reptemp4_
pCR-Blunt2-TOPO (plasmid)
This study UK2386 Repair template for IRE1 DD
(d313-338, 391–444)
reconstitution in CHO-K1 cells
Recombinant
DNA reagent
hIRE1a_19–486_dC_ d313-338
_d391-440_GST_del3UTR _
pCDNA3 (plasmid)
This study UK2401 C-GST-tagged cysteine-free
human IRE1 DD (missing
residues 313–338 and 391–444)
Recombinant
DNA reagent
hIRE1a_19–486_dC_ d313-338
_GST_del3UTR _pCDNA3 (plasmid)
This study UK2404 C-GST-tagged cysteine-free
human IRE1 Dloop
(missing residues 313–338)
Recombinant
DNA reagent
hIRE1a_19–486_dC_ d391-440
_GST_del3UTR _pCDNA3
(plasmid)
This study UK2406 C-GST-tagged cysteine-free
human IRE1 DD
(missing residues 391–444)
Recombinant
DNA reagent
Met_ERdj4_24–120_Ire1a_LDDC_
24–443_AviTag_H6_pET30a (plasmid)
This study UK2408 C-Avi-His6-tagged cysteine-free
chimeric J-ERdj4
human IRE1LD24–444 protein
Recombinant
DNA reagent
pET22b_H7_Smt3_Ire1a_
LD_dC_24_444_P108A
(plasmid)
This study UK2410 N-His6-Smt3-tagged cysteine-free
human IRE1LD P108A
monomeric mutant 24–444
Recombinant
DNA reagent
pET22b_H7_Smt3_Ire1a_
LD_dC_24_444_W125A
(plasmid)
This study UK2411 N-His6-Smt3-tagged
cysteine-free
human IRE1LD W125A
monomeric mutant 24–444
Recombinant
DNA reagent
Met_ERdj4_24–120_
Ire1a_LDDC_24–443_S112C_
AviTag_H6_pET30a
(plasmid)
This study UK2412 C-Avi-His6-tagged
cysteine-free
chimeric
J-ERdj4 human IRE1LD24–444
protein, S112C (FRET probe)
Recombinant
DNA reagent
J4_WT_IRE1_LD_
CHORepairTemplate
(plasmid)
This study UK2425 Repair template for chimeric
J-IRE1 reconstitution in
CHO-K1 cells
Recombinant
DNA reagent
J4_QPD_IRE1_LD_
CHORepairTemplate_
V1 (plasmid)
This study UK2426 Repair template for chimeric
JQPD-IRE1 reconstitution in
CHO-K1 cells
Continued on next page
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Continued
Reagent type
(species) or resource Designation
Source or
reference Identifiers
Additional
information
Recombinant
DNA reagent
Met_ERdJ4_24–120_
Ire1a_LDDC_24–443_P108A_
AviTag_H6_pET30a (plasmid)
This study UK2428 C-Avi-His6-tagged cysteine-free
chimeric J-ERdj4 human
IRE1LD24–444
protein containing
monomerising
mutation P108A
Recombinant
DNA reagent
Met_ErdJ4_24–120_
IRE1a_LDDC_24–390_D313–338_
AviTag_H6_pET30a (plasmid)
This study UK2458 C-Avi-His6-tagged cysteine-free
chimeric J-ERdj4 human IRE1LD DD
protein (313-338, 391-444)
Recombinant
DNA reagent
IRE1a_LDDC
_24–390_D313–338_AviTag_H6
_pET30a (plasmid)
This study UK2459 C-Avi-His6-tagged cysteine-free
human IRE1LD DD
(d313-338, 391–444)
Recombinant
DNA reagent
Met_ERdJ4_24–120_
Ire1a_LDDC_24–443_Q105C_
AviTag_H6_pET30a
(plasmid)
This study UK2558 C-Avi-His6-tagged cysteine-free
chimeric J-ERdj4
human IRE1LD24–444
protein containing
mutation Q105C
Mammalian cell culture
The parental strains for the CRISPR-Cas9-mediated homologous recombination approaches were
the previously described DLD15 dual CHOP::GFP and XBP1s::Turquoise UPR reporter Chinese Ham-
ster Ovary CHO-K1 cell lines (Kono et al., 2017) and have been authenticated as CHO-K1 using the
criteria of successful targeting of essential genes using a species-specific CRISPR whole genome
library, and sequencing of the wild-type or mutant alleles of the genes studied that confirmed the
sequence reported for the corresponding genome. The cell lines have tested negative for myco-
plasma contamination using a commercial kit (MycoAlert (TM) Mycoplasma Detection Kit, Lonza).
None of the cell lines is on the list of commonly misidentified cell lines maintained by the Interna-
tional Cell Line Authentication Committee. The CRISPR-Cas9-mediated mutagenesis strategy and
the transient transfection of GST-tagged IRE1LD was performed with CHO-K1 S21 dual UPR reporter
cells (Sekine et al., 2016). Cells were cultured in Ham’s nutrient mixture F12 (Sigma). All cell media
was supplemented with 10% (v/v) serum (FetalClone-2, Hyclone), 2 mM L-glutamine (Sigma), 100 U/
ml penicillin and 100 mg/ml streptomycin (Sigma). Cells were grown in tissue culture dishes or multi-
well plates (Corning) at 37˚C and 5% CO2. Tunicamycin (Melford) treatment was at 2.5 mg/ml for 16
hr, 2-Deoxyglucose (2DG) (Sigma) treatment at 4 mM for 16 hr and 4m8c (Cross et al., 2012) treat-
ment at 10 mM for 7 days. The drugs were mixed with pre-warmed culture medium and immediately
added to the cells by medium exchange.
Transfection
Cells were transfected using Lipofectamine LTX (Life Technologies) transfection reagent with
reduced serum medium Opti-MEM (Life Technologies) following the manufacturer’s instructions.
Flow cytometry and fluorescence-activated cell sorting (FACS)
To analyse the effect of IRE1 variants expressed from the endogenous Ern1 locus on the UPR
(Figure 1A and B, Figure 4—figure supplement 1A and B), flow cytometry was performed. Cells
were washed once in PBS and collected in PBS containing 4 mM EDTA. Single-cell fluorescent sig-
nals (20,000/sample) were analysed by dual-channel flow cytometry with an LSRFortessa cell analyser
(BD Biosciences). FACS was performed on either a Beckman Coulter MoFlo or a BD FACSMelody
cell sorter. Cells were washed once in PBS and then incubated 5 min in PBS supplemented with
0.5% BSA and 4 mM EDTA before sorting into fresh media. CHOP::GFP fluorescence was detected
with excitation laser at 488 nm, filter 530/30 nm; XBP1s::Turquoise fluorescence with excitation laser
405 nm, filter 450/50 nm and mCherry fluorescence with excitation laser 561, filter 610/20. To gener-
ate clonal cell lines stably expressing a version of IRE1 the transfected cells were treated with 2-
Deoxyglucose to gate for cells showing high CHOP::GFP XBP1s::Turquoise fluorescence.
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Gene manipulation and allele analysis
Cas9 guides were either manually designed following standard guidelines (Ran et al., 2013) or taken
from the CRISPy database (URL: http://staff.biosustain.dtu.dk/laeb/crispy/, (Ronda et al., 2014).
Cells were transfected with the Cas9 and guide constructs and grown for seven days before they
were analysed by flow cytometry or FACS.
For the in vivo mutagenesis strategy (Figure 3B and C and Figure 3—figure supplement 1B), a
series of guides that tiled the two regions of interest, set A covering the putative loop (residues
308–362) and set B covering the tail (residues 368–444) was designed. Set A and set B guide-Cas9
encoding plasmids were transfected singly or in different pairwise combinations into IRE1 wild-type
expressing cells (CHO-K1 S21 CHOP::GFP, XBP1s::Turquoise dual reporter cell line) and pooled to
create population 0 (Figure 3C). Rare de-repressing IRE1 mutants were enriched from the mutage-
nised population by iterative rounds of FACS (populations 1 and 2) followed by a selection against
clones that had acquired IRE1-independent XBP1s::Turquoise reporter expression, as assessed by
their unresponsiveness to the IRE1 inhibitor 4m8c. Genomic DNA was extracted from final clones,
PCR used to amplify the loci of interest and the resultant products were sequenced. The genomic
DNA was extracted from cells by incubation in Proteinase K solution (100 mM Tris-HCl pH 8.5, 5 mM
EDTA, 200 mM NaCl, 0.25% SDS, 0.2 mg/ml Proteinase K) overnight at 50 ˚C. Next, Proteinase K
was heat inactivated at 98 ˚C for 20 min before the supernatant was collected and used as a tem-
plate in PCR reactions before sequencing. To facilitate the interpretation of the sequencing data,
the changes in size of alleles modified by Cas9 was determined by capillary electrophoresis on a
3730xl DNA analyser (Applied Biosystems). For that, sample preparation was performed with one of
the oligonucleotides having a 5’ 6-carboxyfluorescein (FAM) flurophore in the PCR reaction.
Creating clonal cell lines stably expressing IRE1 variants
The activity of IRE1 variants was analysed by introducing them into the endogenous Ern1 locus of
CHO-K1 CHOP::GFP and XBP1s::Turquoise dual UPR reporter cells using a Ern1 null cell line (DIRE1
as described in Kono et al., 2017). Cells were transfected with a Cas9-CRISPR guide construct tar-
geting the Ern1 locus (UK1903) together with the respective repair templates (UK2425 for chimeric
J-IRE1, UK2426 for JQPD-IRE1, UK1968 for wild-type IRE1, UK2384 for IRE1 Dloop, UK2385 for IRE1
Dtail, UK2386 for IRE1 DD) and grown for 7 days before further analysis. Cells that successfully
repaired the IRE1 locus were selected by FACS by gating for cells exhibiting increased XBP1s::Tur-
quoise fluorescence after 2-deoxyglucose treatment. Cells transfected with J-IRE1 as repair template
were additionally transiently transfected with a plasmid encoding SubA wild-type, mutant or an
empty vector (UK1452, UK1459, UK1314 respectively) before FACS. Data shown in Figure 4A and
Figure 4—figure supplement 1A was acquired after transient transfection using a mixed population
of cells and data shown in Figures 1A, B, C and 4B and Figure 4—figure supplement 1B with
clonal cell lines.
Mammalian cell lysis
Cell lysis was performed as described previously (Amin-Wetzel et al., 2017). All reagents were kept
on ice throughout. Cells were washed in PBS, removed from the culture dish in PBS + 1 mM EDTA
with a cell scraper and then pelleted at 370  g for 5 min at 4˚C. Cells were incubated in lysis buffer
(1% Triton X-100, 150 mM NaCl, 20 mM HEPES-KOH pH 7.5, 10% glycerol, 1 mM phenylmethylsul-
phonyl fluoride (PMSF), 4 mg/m Aprotinin, 2 mg/ml Pepstatin A and 2 mM Leupeptin) for 5 min. Next,
the samples were clarified at 21,130 g for 10 min at 4˚C. The supernatant was transferred to a fresh
tube and protein concentration measured with BioRad protein assay reagent (Bio-Rad).
For BiP co-IP experiments, non-specific binding of BiP to protein-A sepharose beads was
decreased by digitonin treatment (Le Gall et al., 2004) to remove non-membrane associated BiP
from cells prior to lysis. After pelleting, cells were washed in HNC buffer (50 mM HEPES-KOH pH
7.5, 150 mM NaCl, 2 mM CaCl2) and then incubated in HNC + 0.1% (w/v) digitonin (Calbiochem) for
10 min. Cells were then washed in HNE buffer (50 mM HEPES-KOH pH 7.5, 150 mM NaCl, 1 mM
EGTA) before proceeding to lysis using lysis buffer supplemented with 10 mM MgCl2, 6 mg/ml glu-
cose and 50 U/ml Hexokinase (H4502 Sigma) to deplete ATP and stabilise BiP-substrate interactions.
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Immunoprecipitation (IP) and GST pull down assays
To analyse the amount of BiP co-immunoprecipitated with endogenously expressed IRE1 variants
(Figures 1C and 4B) or transiently transfected IRE1LD-GST variants (Figure 4C), Protein A sepharose
4B beads (Zymed Invitrogen) or Glutathione (GSH) Sepharose 4B beads (GE Healthcare) were equili-
brated in lysis buffer. Next, 20 ml beads per sample and anti-IRE1a were added to lysates and left
rotating for 1 hr at 4˚C. The beads were then washed in lysis buffer and residual liquid removed
using a syringe. The protein from the beads was eluted in SDS sample buffer containing 20 mM
DTT.
Antibodies
Anti-mouse IRE1a serum (NY200) was used for IP and immunoblot detection of endogenous IRE1a
(Bertolotti et al., 2000). An anti-hamster BiP antibody was used for immunoblot detection of
endogenous BiP (Avezov et al., 2013). Anti-GST serum was used for immunoblot detection of GST
fusion proteins (Ron and Habener, 1992).
Reducing/non-reducing SDS-PAGE and immunoblotting
Samples were run on standard polyacrylamide Tris-HCl gels and transferred to Immobilon-P PVDF
membrane (Pore size 0.45 mm, Sigma). Membranes were then blocked in 5% (w/v) dried skimmed
milk in PBS, washed in TBS with 0.1% Tween-20 and exposed to various primary antibodies/antisera
followed by incubation with IRDye fluorescently labelled secondary antibodies. Imaging was carried
out with using a LICOR CLx Odyssey infrared imager. Coomassie-staining was carried out with
Instant Blue (Expedeon). Signal quantitation from SDS-PAGE gels or from immunoblots was carried
out using the ImageJ software (NIH).
Protein purification
Human IRE1LD
His6-Smt3-IRE1
LD (UK2048, UK2079, UK2042, UK2370, UK2410, UK2411, UK2516, UK2045, UK2304)
and His6-Avitag-IRE1
LD (UK2412, UK2246, UK2459, UK2408, UK2458) variants were encoded on a
pET-derived vector (Novagen) as fusion proteins and expressed in T7 Express lysY/Iq E. coli cells
(NEB). IRE1LD Q105C variants (UK2045, UK2304) used to make disulphide-linked dimeric IRE1LD Q105C
species were expressed in Origami B(DE3) cells (Novagen).
Protein purification was performed as described in Amin-Wetzel et al. (2017). Bacterial cultures
were grown at 37˚C in LB medium containing 100 mg/ml ampicillin until an OD600nm of 0.6–0.8 was
reached. Expression was induced with 0.5 mM IPTG and the cells were incubated for 16 hr at 18˚C.
After sedimentation of the cells by centrifugation the pellets were resuspended in TNGM buffer (50
mM Tris-HCl pH 7.4, 500 mM NaCl, 10% glycerol, 1 mM MgCl2). The cell suspension was supple-
mented with 0.1 mg/ml DNaseI and protease inhibitors (2 mM PMSF, 4 mg/ml Pepstatin, 4 mg/ml
Leupeptin, 8 mg/ml Aprotinin) and lysed by repeated passage through a high-pressure homogenizer
(EmulsiFlex-C3, Avestin). After clarification of the lysates by centrifugation at 20,000  g for 30 min
the supernatant was removed and incubated for 60 min at 4˚C with Ni-NTA agarose (Qiagen) (0.5 ml
per liter of bacterial culture). The matrix was washed two times with 50 ml of TNGMI wash buffer (50
mM Tris-HCl pH 7.4, 500 mM NaCl, 10% glycerol, 1 mM MgCl2, 20 mM imidazole). The matrix was
transferred to a gravity-flow column and the flow-through was collected after a wash with one bed
volume of elution buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 10% glycerol, 250 mM imidazole).
The protein solutions were concentrated using 30 kDa MWCO centrifugal filters (Amicon Ultra;
Merck Millipore), flash frozen and stored at  80 ˚C.
For the preparation of UK2042, UK2045, UK2410, UK2411 and UK2516 1.5 mg/ml His6-Ulp1
(UK1249) and 1 mM TCEP were added to the eluates and incubated overnight at 4˚C, whilst being
dialysed against HKM buffer (50 mM HEPES-KOH pH 7.4, 150 mM KCl, 10 mM MgCl2). To remove
the cleaved His6-Smt3-tag and the His6-Ulp1 the solution was again incubated with Ni-NTA agarose
for 60 min at 4˚C. After passing the sample through a gravity-flow column the final eluate was col-
lected, concentrated using 30 kDa MWCO centrifugal filters, flash frozen and stored at  80 ˚C.
For the preparation of UK2304, the dialysis overnight was performed against TN buffer (150 mM
NaCl, 50 mM Tris-HCl pH 7.4). After removal of uncleaved protein and His6-Smt3 the protein solu-
tion was then diluted to 75 mM NaCl, 50 mM Tris-HCl pH 7.4, 10 mM imidazole and bound to an
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anion exchange column. The protein was eluted in 10 mM Tris-HCl pH 7.4 50–500 mM NaCl and
then incubated with 5 mM oxidised glutathione overnight. The sample was then separated on a
Superdex 200 10/300 GL gel filtration column equilibrated in TN buffer and appropriate fractions
collected and concentrated using 30 kDa MWCO centrifugal filters, flash frozen and stored at  80 ˚
C.
The purification of the FRET probes (UK2048, UK2076, UK2412, UK2370) was performed as
described above with 1 mM TCEP contained in all buffers. Eluted fractions were buffer exchanged
into HKMT buffer (50 mM HEPES-KOH pH 7.4, 150 mM KCl, 10 mM MgCl2, 1 mM TCEP) using a
CentiPure P10 desalting column (Generon) and labelled with threefold molar excess of Oregon
Green-iodoacetic acid (ThermoFisher) or TAMRA-maleimide (Sigma) to make IRE1LD R234C-OG
(UK2048), IRE1LD R112C-TMR (UK2076), J-IRE1S112C-TMR (UK2412) and IRE1LD DD S112C-TMR
(UK2370). The reaction proceeded at room temperature in the dark overnight and was quenched by
the addition of 5 mM DTT. The reaction mixture was passed through a CentiPure P10 gravity-desalt-
ing column (Generon) equilibrated in HKM buffer and afterwards through a Superdex 200 10/300 GL
gel filtration column equilibrated in HKG (50 mM HEPES-KOH pH 7.4, 150 mM KCl, 10% (v/v) glyc-
erol) buffer. Appropriate fractions were collected, concentrated, flash frozen and stored at  80 ˚C.
For the streptavidin pull down (Figure 1D and Figure 5B) and the Bio-Layer Interferometry (BLI)
measurements (Figure 5A and Figure 5—figure supplement 1A and B), chimeric J-IRE1LD
(UK2408), J-IRE1LD DD (UK2458), J-IRE1LD P108A (UK2428) and J-IRE1LD Q105C SS(UK2558), wild-type
IRE1LD (UK2246) and IRE1LD DD (UK2459) were biotinylated enzymatically with E. coli BirA to create
biotinylated J-IRE1LD-bio and IRE1LD-bio variants, respectively.
Hamster ERdj4
Expression and purification of ERdj4 and variants was performed according to the protocol previ-
ously described in Amin-Wetzel et al. (2017). The constructs were expressed as fusion proteins with
an N-terminal His6-Smt3 (UK2012 for wild-type ERdj4) or with both, an N-terminal His6-Smt3 and
C-terminal MBP (UK2108 for wild-type and UK2119 for QPD ERdj4) in Origami B(DE3) cells. Cells
were grown and lysed as described above for His6-Smt3 tagged proteins. Ni-NTA chromatography
was performed as described above. His6-Smt3-ERdj4-MBP variants were further purified on a S200
10/300 GL column equilibrated in HKM buffer.
Hamster BiP
BiP and BiP variants (UK173, UK182, UK984) were purified as previously described in Petrova et al.
(2008); Preissler et al. (2015a).
Streptavidin pull down assays
To assess BiP binding to IRE1LD variants in the presence and absence of J-domain-mediated hyper-
affinity (Figure 1D and Figure 5B, respectively), 20 ml Dynabeads MyOne Streptavidin C1 (Thermo
Fisher Scientific) per sample were used. Analysis was performed in HKMGTw buffer (50 mM HEPES-
KOH pH 7.4, 150 mM KCl, 10 mM MgCl2, 10% (v/v) glycerol, 0.05% TWEEN-20). Reactions con-
tained 5 mM biotinylated IRE1LD proteins (UK2246, UK2408, UK2459), 8 mM ERdj4 (UK2012), 30 mM
BiP variants (UK173, UK182, UK984), and 2 mM ATP. In experiments conducted in presence of a
J-domain the samples were incubated for 20 min at 30˚C. In experiment conducted in absence of a
J-domain for 16 hr at 4˚C. Next, the samples were clarified at 21,130  g for 5 min and an excess of
ice cold 1 mM ADP was added to the supernatant followed by the addition of Dynabeads. Binding
was performed for 45 min at 4˚C followed by washing in assay buffer supplemented with 1 mM ADP
(for the ATP wash 2 mM ATP was used instead). The samples were eluted with 1x SDS sample
buffer.
Analytical size-exclusion chromatography (SEC)
To assess the oligomeric state of wild-type IRE1LD (UK2042), IRE1LD W125A (UK2411) and IRE1LD P108A
(UK2410) and IRE1LD DD (UK2516) in presence and absence of MPZ-N peptide (GeneScript, Piscat-
away, NJ), SEC was performed (Figure 2A and B, Figure 2—figure supplement 1A and Figure 5—
figure supplement 1C). Samples were run through a SEC-3 HPLC column (300 A˚ pore size; Agilent
Technologies) on an Agilent infinity HPLC system equilibrated in HKM buffer at a flow rate of 0.3 ml/
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min. Samples were pre-incubated in a final volume of 20 ml for 30 min at 30˚C before clarification at
21,130  g for 5 min and subsequent injection of 10 ml. Runs were performed at 25˚C and A280
absorbance and TAMRA (TMR, excitation 544 nm and emission 572 nm) traces were recorded.
Bio-layer interferometry (BLI) experiments
Experiments were performed on an Octet RED96 (Pall ForteBio) in HKM buffer supplemented with
0.05% Triton X-100. In the sequential dipping experiments (Figure 5A and Figure 5—figure supple-
ment 1A and B), streptavidin biosensors were loaded with the indicated biotinylated IRE1LD variants
(UK2246, UK2428, UK2558, UK2459, UK2408, UK2458) to approximately 1 nm displacement, washed
in assay buffer, and then sequentially dipped in wells containing the indicated analytes. For the two-
component system (Figure 5A and Figure 5—figure supplement 1B) with the chimeric J-IRE1LD
fusions 0.15 or 0.5 mM BiP wild-type (UK173), 0.5 mM BiPV461F (UK182) and 2 mM ATP were used
and for the three-protein system (Figure 5—figure supplement 1A) 2 mM BiP (UK172), 6.8 mM
ERdj4 full-length (UK2012) or J-domain (UK2041) and 2 mM ATP. After each association, the sensor
was dipped into buffer containing 2 mM ATP to allow for BiP dissociation. Data were normalised to
the signal after the first wash step.
Kinetic FRET experiments
To assess the effect of a fused J-domain to IRE1LD (Figure 1E) or the introduction of deletions into
the IRE1LD on Erdj4 and BiP-mediated monomerisation (Figure 5C) kinetic FRET measurements
were performed. For this, heterodimeric FRET pairs consisting of an OG-labelled wild-type donor
molecule combined with a TMR-labelled mutant acceptor molecule were employed. Although this
experimental setup reduces the dynamic range of the measurements, it is compensated by the
greater comparability of detecting changes in donor fluorescence in presence of a constant IRE1LD-
OG donor molecule. IRE1LD-OG donor (UK2048-OG) and IRE1LD-TMR acceptor (UK2076-TMR,
UK2412-TMR, or UK2370-TMR) molecules were combined at a 1:2 ratio and incubated at room tem-
perature in the dark for two hours. In Figure 1E 30 mM BiP, 2.5 mM ERdj4 (UK2108), and 0.2 mM
IRE1LD-FRET pair were combined in HKMGTw buffer and incubated for 30 min. To initiate the reac-
tion, 2 mM ATP with an ATP regeneration system (8 mM phosphocreatine, 0.016 mg/ml creatine
kinase) was added. In Figure 5C, 30 mM BiP, 2.5 mM ERdj4 full-length (UK2108) or J-ERdj4 (UK2041),
and 0.2 mM pre-equilibrated IRE1LD-FRET pair were combined in HKMGTw buffer. The donor fluo-
rescence was followed with a CLARIOstar plate reader (excitation: 470–15 nm, emission: 524–20 nm)
recording signals every 30 s. The donor fluorescence was background subtracted arising from a well
containing buffer only and analysed with the Prism GraphPad 7.0 software.
Differential scanning fluorimetry (DSF)
DSF experiments were performed on a CFX96 Real-Time System (Bio-Rad). Reactions were trans-
ferred into 96-well qPCR plates (Thermofisher) (final volume 25 ml). Protein concentrations were 5
mM, ligands at the concentration indicated in the figure (62.5–1000 mM), and SYPRO Orange (Ther-
mofisher) dye at a 10x concentration in HKM buffer. Where indicated 1 mM TCEP was included.
Over a temperature range of 20–95˚C fluorescence of the SYPRO Orange dye was monitored using
the SYBR-FAM filter set. Data was then analysed in Prism GraphPad 7.0, with melting temperature
calculated as the global minimum of the negative first derivative of the respective fluorescent unit
melt curves. Data shown in Figure 2—figure supplement 1D indicate a correlation between the
monomer-dimer equilibrium and the Tm of IRE1
LD. In line with that, titrational analysis of IRE1LD and
variants reported on an increased Tm at higher protein concentrations, however it did not result in a
two state transition representing the monomer and the dimer because of oligomerisation (data not
shown). Moreover, the lower Tm of the monomeric variants could reflect an intrinsic destabilisation
of the protein caused by the point mutation.
Fluorescence polarisation (FP)
To characterise the binding of FAM labelled MPZ-N peptide [5-FAM-LIRYCWLRRQAA) (as described
in Karago¨z et al. (2017), from GeneScript, Piscatawy, NJ] to IRE1LD or disulphide-linked IRE1LD
Q105C SS. (Figure 2D). FP was measured with a CLARIOstar plate reader. Using excitation at 496 nm
and measuring emission at 519–550 nm, parallel and perpendicular fluorescence of the FAM
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fluorophore was detected. Whilst FAM-MPZN was kept at 100 nM in reactions the concentrations of
IRE1LD variants are detailed in the legend of Figure 2D. Samples containing the respective compo-
nents were prepared in 25 ml and then 20 ml were transferred to a black flat-bottomed 384 well plate
and incubated for 30 min prior to reading. Fluorescence readings were corrected by subtracting
fluorescence from a well containing only buffer. The average of three readings (spaced at 30 s inter-
vals) per well was taken as one repeat and the average of three independent repeats was used for
Figure 2D. Anisotropy was calculated according to Equation 1:
A¼ Ipara  Iperp
Iparaþ 2Iperp (1)
The data was fit to Equation 2:
rfreeþ
rmax  rfree
  h
X½ hþKh (2)
whereby rfree represents anisotropy in the absence of protein, rmax the theoretical maximal anisot-
ropy, [X] the protein concentration and h the hill-coefficient. Curve fitting was per- formed with Prism
GraphPad 7.0 and minimal constraints to obtain K1/2max values with R
2 values > 0.9. As this equation
does not consider the equilibria between IRE1LD dimers and oligomers, the K1/2max value does not
reflect the dissociation constant.
Hydrogen exchange mass spectrometry (HX-MS)
For Figure 6A and Figure 6—figure supplement 1A, 5 mM wild-type IRE1LD (UK2042) or mono-
meric IRE1LD W125A (UK2411) and IRE1LD P108A (UK2410) were pre-incubated for 30 min at 30 ˚C in
HKM buffer. The samples were then diluted 1:20 in D2O buffer supplemented with 10 mM ADP
(HKM buffer was lyophilised and re-dissolved in pure D2O at least three times) and incubated for 30
and 300 s at 30˚C. Deuterated samples were quenched 1:1 with ice-cold quench buffer (2% formic
acid), immediately subjected to LC-MS using an Agilent UPLC and a MaXis mass spectrometer
(Bruker). For each experiment at least one unexchanged sample and one fully deuterated control
were measured. The unexchanged protein sample was diluted 1:20 in H2O buffer. The fully deuter-
ated sample (protein in HKM buffer containing 6 M guanidine hydrochloride, lyophilised and re-dis-
solved in pure D2O at least three times) was treated as the other samples. For HX-MS experiments
presented in Figure 6C, Figure 6—figure supplements 1B, C, 5 mM wild-type IRE1LD (UK2042) or
IRE1LD DD (UK2516) was incubated with 30 mM BiP wild-type (UK173) or V461F mutant (UK182), 6 mM
ERdj4 wild-type (UK2108) or ERdj4 QPD mutant (UK2119) and 2 mM ATP in HKM buffer. Dilution in
D2O buffer and subsequent steps were performed as described above. Data analysis was performed
manually (Data Analysis 4.1, Bruker).
HX-MS data analysis of the bimodal distributed isotope clusters
In order to observe an amide hydrogen exchange, a structure-specific H-bond between a peptide
backbone amide hydrogen and an H-bond acceptor has to open. This opening occurs by unfolding
of secondary structures within the native conformation of the protein according to Equation 3:
FðHÞ
kcl
  *)  
kop
UðHÞ! ½OD =D2OkchUðDÞ
kop
  *)  kcl FðDÞ (3)
Hereby, F and U indicate the folded and unfolded state of the structural element, respectively.
The conversions between these conformations are determined by kop and kcl, representing the
opening and closing rate constants. The intrinsic chemical exchange rate is indicated by kch.
There are two extreme cases, distinguishing the so-called EX1 and EX2 exchange regimes. In
case of EX1 kcl is much smaller than kch. Therefore, all amide protons exchange at once upon unfold-
ing and the observed rate is practically equal to the opening rate kop of the structural element. This
type of exchange kinetics is characterised by a bimodal distribution of the isotope peaks in peptic
mass spectra showing two separate, interconverting subpopulations (Figure 7—figure supplement
1A). Notably, the EX1 exchange regime occurs only rarely under native conditions and is more likely
to be observed in presence of chemical denaturants as they decrease the closing rate kcl without
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affecting the intrinsic chemical exchange rate kch by interfering with H-bond and hydrophobic core
formation. EX2 is most commonly observed, as under native state conditions kcl is generally much
greater than the intrinsic chemical exchange rate kch. Hence, many opening and closing cycles are
necessary in order to exchange all amide protons to deuterons, which is visible by a gradual increase
of the average mass in the peptic mass spectra whilst the isotopic distribution remains roughly the
same (Rist et al., 2003). By comparing IRE1LD with the monomeric variants we identified regions
exhibiting increased deuteron incorporation in the monomeric state of the protein, with some of
them revealing bimodal distributions of the isotope clusters. In order to calculate the contribution of
each subpopulation to the peak intensities, an equation for two Gaussian distributions was fitted to
the isotope peak maxima versus m/z plots using the Prism GraphPad 7.0 software:
I ¼ A1
s  ffiffiffiffiffiffi2pp  e
 1
2
 1
 
s
  2
þ A2
s  ffiffiffiffiffiffi2pp  e
 1
2
 2
 
s
  2
(4)
Hereby, A1/2 represents the area of the two peaks; m, the m/z values;  , the means of the Gauss-
ian distributions, representing the centroid of each of the two subpopulations; and s, the standard
deviation of the Gaussian distributions, corresponding to the width of the isotope peak distribution.
For each peptide exhibiting a bimodal distribution all intensity values belonging to one incubation
time in D2O were globally fitted assuming that s and m1/2 are constant. Independent experiments
were treated independently. Next, the fitted parameters A1/2, m1/2 and s were used to calculate the
proportion of the low and high mass subpopulation for each individual isotope peak.
Crystallisation, data collection and structure determination
Initial crystals were obtained by screening commercial crystallisation plates via 200 nl protein
(16 mg/ml) plus 200 nl well solution in 96-well sitting drop plates at 20˚C. The best diffraction data-
set was collected from a crystal grown in 9% MPD, 0.1 M HEPES-KOH pH 7.5 microseeded
(D’Arcy et al., 2007) from diluted initial crystals in 20% MPD, 0.1 M HEPES-KOH pH 7.5. Crystals
were briefly soaked into 9% MPD, 0.1 M HEPES-KOH pH 7.5, 25% (v/v) glycerol and cryocooled in
liquid nitrogen. Diffraction data was collected at beamline I04-1 in the Diamond Synchrotron Light
Source (DLS) and processed by the XIA2 pipeline (Winter, 2010) implementing Dials (Winter et al.,
2018) for indexing and integration, Pointless for space group determination, and Aimless for scaling
and merging (Evans, 2011). The structure was solved by searching the published IRE1LD core struc-
ture (PDB 2HZ6) using Phaser (McCoy et al., 2007). One molecule of IRE1 was found in one asym-
metric unit, but the electron density around Cys105 and the SG-SG bond length suggested that
Cys105 formed a disulphide bond with the symmetric Cys105. Further refinement was performed
iteratively using COOT (Emsley et al., 2010) and refmac5 (Winn et al., 2001) (Table 1) in CCP4i2
interface (Potterton et al., 2018) and phenix.refine (Liebschner et al., 2019). MolProbity
(Chen et al., 2010) was consulted throughout the refinement process. Molecular graphics were gen-
erated with PyMOL Molecular Graphics System, Educational-use-only version 4.5 Schrodinger, LLC).
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